var title_f14_17_14608="Left upper lobe TB infiltrate";
var content_f14_17_14608=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F79049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F79049&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left upper lobe infiltrate and possible cavity in pulmonary TB",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 338px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left upper lobe infiltrate and possible cavity in an adolescent with sputum-smear-positive pulmonary tuberculosis. This patient had a one month history of cough, 8 pound weight loss and night sweats.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey R Starke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14608=[""].join("\n");
var outline_f14_17_14608=null;
var title_f14_17_14609="Squamous cell carcinoma MRI";
var content_f14_17_14609=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F71057&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F71057&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 515px\">",
"   <div class=\"ttl\">",
"    Squamous cell carcinoma of the right lower lobe",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 495px; height: 260px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left panel: Coronal MR scan demonstrates transdiaphragmatic extension of a right lower lobe squamous cell carcinoma into the liver. This is a T4 tumor. Right panel: Sagittal sequence demonstrates transdiaphragmatic extension into the liver and a small pleural effusion (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14609=[""].join("\n");
var outline_f14_17_14609=null;
var title_f14_17_14610="Secondary syphilis - oral fissure";
var content_f14_17_14610=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F66008&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F66008&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Secondary syphilis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A fissured papule is present at the oral commissure in this patient with secondary syphilis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14610=[""].join("\n");
var outline_f14_17_14610=null;
var title_f14_17_14611="Patient information: Pneumonia in children (The Basics)";
var content_f14_17_14611=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/17120\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/31/27121\">",
"         Signs of severe trouble breathing (retractions)",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?38/10/39074\">",
"         Patient information: Bronchiolitis (and RSV) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?13/7/13427\">",
"         Patient information: Cough in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?17/55/18291\">",
"         Patient information: Cough, runny nose, and the common cold (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/40/40578\">",
"         Patient information: Fever in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?32/47/33522\">",
"         Patient information: Flu (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/18/36130\">",
"         Patient information: Pneumonia in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/22/28003\">",
"         Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/7/18547\">",
"         Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?27/19/27958\">",
"         Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/23/37235\">",
"         Patient information: Fever in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?13/57/14225\">",
"         Patient information: Pneumonia prevention (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/44/40643\">",
"         Patient information: The common cold in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Pneumonia in children (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/pneumonia-in-children-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H11397153\">",
"      <span class=\"h1\">",
"       What is pneumonia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Pneumonia is an infection of the lungs that causes coughing, fever, and trouble breathing. It is a serious illness, especially in young children. Pneumonia can be caused by bacteria or viruses. The most likely cause of pneumonia depends on the child&rsquo;s age:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        In children older than 5 years, pneumonia is more likely to be caused by bacteria.",
"       </li>",
"       <li>",
"        In babies and children younger than 5 years, pneumonia is more likely to be caused by a virus.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11397168\">",
"      <span class=\"h1\">",
"       What are the symptoms of pneumonia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Common symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Cough",
"       </li>",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Breathing faster than normal",
"       </li>",
"       <li>",
"        Trouble breathing or pain when breathing in",
"       </li>",
"       <li>",
"        Restlessness or trouble feeding (in babies)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Not all children with pneumonia have the same symptoms. But if your child seems sick and has both a cough and a fever, he or she might have pneumonia.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11397183\">",
"      <span class=\"h1\">",
"       Should my child see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If you think your child might have pneumonia, see a doctor or nurse right away. Pneumonia can be very serious in children, especially if it is not treated right away.",
"     </p>",
"     <p>",
"      <strong>",
"       Call 9-1-1",
"      </strong>",
"      for an ambulance if your child:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Stops breathing",
"       </li>",
"       <li>",
"        Starts to turn blue or very pale",
"       </li>",
"       <li>",
"        Has a very hard time breathing (",
"        <a class=\"graphic graphic_figure graphicRef59786 \" href=\"UTD.htm?26/31/27121\">",
"         figure 1",
"        </a>",
"        )",
"       </li>",
"       <li>",
"        Starts grunting",
"       </li>",
"       <li>",
"        Looks like he or she is getting tired of having to work so hard to breathe",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If a doctor or nurse thinks your child might have pneumonia, he or she will do an exam and listen to your child&rsquo;s breathing. He or she might also take an X-ray of your child&rsquo;s chest.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11397198\">",
"      <span class=\"h1\">",
"       How is pneumonia treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment depends on the child&rsquo;s age, how serious the pneumonia is, and whether it is caused by bacteria or a virus. Some children who are very sick, especially young children or babies, might need to be treated in the hospital.",
"     </p>",
"     <p>",
"      Pneumonia that is caused by bacteria is treated with antibiotics. Antibiotics are medicines that kill bacteria. They are available in pill or liquid form. Make sure that your child takes all of his or her antibiotics, even if he or she starts feeling better before finishing them!",
"     </p>",
"     <p>",
"      Antibiotics do",
"      <strong>",
"       not",
"      </strong>",
"      help with pneumonia that is caused by a virus. But your child&rsquo;s doctor or nurse might try other medicines if he or she thinks they will help.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11397215\">",
"      <span class=\"h1\">",
"       How soon will my child feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most",
"      <strong>",
"      </strong>",
"      children who are treated with antibiotics start to feel better 2 to 3 days after they start taking the medicine. Even so, your child might still feel tired or have a cough for a few weeks or even months after being treated. It might also be a few months before he or she can breathe comfortably while exercising.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11397230\">",
"      <span class=\"h1\">",
"       How should I take care of my child at home?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Try to keep your child as comfortable as possible, and make sure that he or she gets lots of rest. You should also give your child plenty of fluids to drink. For babies and very young children, it might help to offer small amounts of fluids frequently (instead of large amounts less often).",
"     </p>",
"     <p>",
"      Medicines such as",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?19/35/20021?source=see_link\">",
"       acetaminophen",
"      </a>",
"      &nbsp;(sample brand name: Tylenol&reg;) or",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"       ibuprofen",
"      </a>",
"      &nbsp;(sample brand names: Advil&reg;, Motrin&reg;) can help relieve pain and fever. The correct dose depends on your child&rsquo;s weight, so ask your child&rsquo;s doctor how much to give.",
"     </p>",
"     <p>",
"      Do",
"      <strong>",
"       not",
"      </strong>",
"      give your child medicines that quiet a cough. These medicines don&rsquo;t usually work well, and they can have serious side effects in children. Also, do not give",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?6/12/6342?source=see_link\">",
"       aspirin",
"      </a>",
"      or medicines that contain aspirin to children younger than 18 years. In children, aspirin can cause a serious problem called Reye syndrome.",
"     </p>",
"     <p>",
"      Call your child&rsquo;s doctor or nurse if your child does not seem to be getting better after 2 days. Your child might need a different type of treatment.",
"      <br/>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11397247\">",
"      <span class=\"h1\">",
"       What can I do to keep my child from getting pneumonia again?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Wash your child&rsquo;s hands often with soap and water. It is one of the best ways to prevent the spread of infection. You can use an alcohol rub instead, but make sure the hand rub gets everywhere on your child&rsquo;s hands.",
"     </p>",
"     <p>",
"      There are several vaccines that help to protect against pneumonia. Talk to your child&rsquo;s doctor or nurse about which vaccines your child should get, and when he or she should get them.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11397262\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/40/40578?source=see_link\">",
"       Patient information: Fever in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/7/13427?source=see_link\">",
"       Patient information: Cough in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/10/39074?source=see_link\">",
"       Patient information: Bronchiolitis (and RSV) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/47/33522?source=see_link\">",
"       Patient information: Flu (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/55/18291?source=see_link\">",
"       Patient information: Cough, runny nose, and the common cold (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/22/28003?source=see_link\">",
"       Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/7/18547?source=see_link\">",
"       Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/18/36130?source=see_link\">",
"       Patient information: Pneumonia in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/44/40643?source=see_link\">",
"       Patient information: The common cold in children (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/19/27958?source=see_link\">",
"       Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/23/37235?source=see_link\">",
"       Patient information: Fever in children (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/57/14225?source=see_link\">",
"       Patient information: Pneumonia prevention (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?14/17/14611?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 17120 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-427C511A25-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14611=[""].join("\n");
var outline_f14_17_14611=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11397153\">",
"      What is pneumonia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11397168\">",
"      What are the symptoms of pneumonia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11397183\">",
"      Should my child see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11397198\">",
"      How is pneumonia treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11397215\">",
"      How soon will my child feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11397230\">",
"      How should I take care of my child at home?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11397247\">",
"      What can I do to keep my child from getting pneumonia again?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11397262\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/17120\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/31/27121\">",
"      Signs of severe trouble breathing (retractions)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/10/39074?source=related_link\">",
"      Patient information: Bronchiolitis (and RSV) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/19/27958?source=related_link\">",
"      Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/7/13427?source=related_link\">",
"      Patient information: Cough in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/55/18291?source=related_link\">",
"      Patient information: Cough, runny nose, and the common cold (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/23/37235?source=related_link\">",
"      Patient information: Fever in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/40/40578?source=related_link\">",
"      Patient information: Fever in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/47/33522?source=related_link\">",
"      Patient information: Flu (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/18/36130?source=related_link\">",
"      Patient information: Pneumonia in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/57/14225?source=related_link\">",
"      Patient information: Pneumonia prevention (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/44/40643?source=related_link\">",
"      Patient information: The common cold in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/22/28003?source=related_link\">",
"      Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/7/18547?source=related_link\">",
"      Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_17_14612="Chest pain ED approach";
var content_f14_17_14612=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F66425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F66425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 621px\">",
"   <div class=\"ttl\">",
"    Emergency department approach to chest pain",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 601px; height: 794px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ACS: acute coronary syndrome; ASA: aspirin; CXR: chest x-ray; ECG: electrocardiogram; HF: heart failure; PCI: percutaneous coronary intervention.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14612=[""].join("\n");
var outline_f14_17_14612=null;
var title_f14_17_14613="Talar fracture classification";
var content_f14_17_14613=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F53096&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F53096&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 510px\">",
"   <div class=\"ttl\">",
"    Hawkins classification of talar neck fractures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 490px; height: 438px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Type I, nondisplaced fracture of the talar neck. B) Type II, displaced talar neck fracture with subluxation or dislocation of the subtalar joint. C) Type III, displaced talar neck fracture with associated dislocation of the talar body from both the subtalar and tibiotalar joints. D) Type IV, as suggested by Canale and Kelly, displaced talar neck fracture with an associated dislocation of the talar body from subtalar and tibiotalar joints and dislocation of the head and neck fragment from the talonavicular joint.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Jarvis JG, Moroz PJ. Fractures and Dislocations of the Foot. In: Rockwood and Wilkins' Fractures in Children, 6th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14613=[""].join("\n");
var outline_f14_17_14613=null;
var title_f14_17_14614="Ibuprofen: Patient drug information";
var content_f14_17_14614=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ibuprofen: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=see_link\">",
"     see \"Ibuprofen: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/48/7946?source=see_link\">",
"     see \"Ibuprofen: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F181456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Addaprin [OTC];",
"     </li>",
"     <li>",
"      Advil&reg; Children's [OTC];",
"     </li>",
"     <li>",
"      Advil&reg; Infants' [OTC];",
"     </li>",
"     <li>",
"      Advil&reg; Migraine [OTC];",
"     </li>",
"     <li>",
"      Advil&reg; [OTC];",
"     </li>",
"     <li>",
"      Caldolor&reg;;",
"     </li>",
"     <li>",
"      I-Prin [OTC];",
"     </li>",
"     <li>",
"      Ibu-200 [OTC];",
"     </li>",
"     <li>",
"      Ibu&reg;;",
"     </li>",
"     <li>",
"      Midol&reg; Cramps &amp; Body Aches [OTC];",
"     </li>",
"     <li>",
"      Motrin&reg; Children's [OTC];",
"     </li>",
"     <li>",
"      Motrin&reg; IB [OTC];",
"     </li>",
"     <li>",
"      Motrin&reg; Infants' [OTC];",
"     </li>",
"     <li>",
"      Motrin&reg; Junior [OTC];",
"     </li>",
"     <li>",
"      NeoProfen&reg;;",
"     </li>",
"     <li>",
"      Proprinal&reg; [OTC];",
"     </li>",
"     <li>",
"      TopCare&reg; Junior Strength [OTC];",
"     </li>",
"     <li>",
"      Ultraprin [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F181457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Advil&reg;;",
"     </li>",
"     <li>",
"      Advil&reg; Children's;",
"     </li>",
"     <li>",
"      Apo-Ibuprofen&reg;;",
"     </li>",
"     <li>",
"      Motrin&reg; (Children's);",
"     </li>",
"     <li>",
"      Motrin&reg; IB;",
"     </li>",
"     <li>",
"      Novo-Profen;",
"     </li>",
"     <li>",
"      Nu-Ibuprofen",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10029822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700782",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of very bad and sometimes deadly heart and blood vessel side effects like heart attack and stroke. The risk may be greater if you have heart disease or risks for heart disease. The risk may be greater with long-term use. Do not use this drug right before or after bypass heart surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700792",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of ulcers or bleeding from the stomach or bowel. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain, swelling, and fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease painful period (menstrual) cycles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691733",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat arthritis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691861",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat gout attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691956",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat migraine headaches.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691647",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop early labor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702283",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ibuprofen, aspirin, NSAIDS, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 24 weeks pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029828\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697235",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had an ulcer or bleeding from your stomach or bowel, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696862",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take colestipol or cholestyramine within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697079",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking aspirin to stop a heart attack, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have PKU, talk with your doctor. Some products have phenylalanine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029829\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029831\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling or pain of hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Black, tarry, or bloody stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blood in the urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029826\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food to stop an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694604",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chewable tablet: Chew or crush well. Mix crushed tablet with food. Do not swallow it whole.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694249",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (drops, suspension) if you cannot swallow pills. Shake suspension well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10029827\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10029832\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699239",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect caplets, drops, and tablets from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11763 Version 43.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-8BB6C55152-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14614=[""].join("\n");
var outline_f14_17_14614=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181456\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F181457\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029822\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029824\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029823\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029828\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029829\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029831\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029826\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029827\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029832\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029833\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=related_link\">",
"      Ibuprofen: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/48/7946?source=related_link\">",
"      Ibuprofen: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_17_14615="Pathogenesis of ventricular arrhythmias in heart failure and cardiomyopathy";
var content_f14_17_14615=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis of ventricular arrhythmias in heart failure and cardiomyopathy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/17/14615/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/17/14615/contributors\">",
"     Philip J Podrid, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/17/14615/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/17/14615/contributors\">",
"     Wilson S Colucci, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/17/14615/contributors\">",
"     Brian Olshansky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/17/14615/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/17/14615/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/17/14615/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both atrial and ventricular arrhythmias are common in patients with heart failure (HF) and cardiomyopathy, regardless of underlying etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/1\">",
"     1",
"    </a>",
"    ]. They can cause symptoms, morbidity (such as stroke due to embolization with atrial fibrillation), and may be responsible for sudden cardiac death.",
"   </p>",
"   <p>",
"    The pathogenesis of ventricular arrhythmias in patients with HF and cardiomyopathy will be reviewed here. The indications for and methods of treatment of ventricular arrhythmias and of atrial fibrillation in these patients are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/47/21241?source=see_link\">",
"     \"Ventricular arrhythmias in heart failure and cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24042?source=see_link\">",
"     \"Atrial fibrillation in patients with heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are multiple factors responsible for the frequency of ventricular arrhythmias in patients with heart failure (HF) and cardiomyopathy. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Underlying structural disease",
"     </li>",
"     <li>",
"      Mechanical factors",
"     </li>",
"     <li>",
"      Neurohormonal factors",
"     </li>",
"     <li>",
"      Electrolyte abnormalities",
"     </li>",
"     <li>",
"      Ischemia",
"     </li>",
"     <li>",
"      Drugs",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Underlying structural disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extensive myocardial damage and fibrosis or the loss of cell-to-cell coupling in patients with dilated cardiomyopathy provides the proper substrate for reentry, the mechanism thought to be responsible for most ventricular arrhythmias. In the cardiomyopathic heart, for example, new reentrant wave fronts may be initiated by epicardial breakthrough of the impulse followed by a line of conduction block parallel to the epicardial fiber orientation, suggesting the importance of increased fibrosis and the resulting increase in tissue anisotropy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/62/42984?source=see_link\">",
"     \"Reentry and the development of cardiac arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A focal mechanism may also contribute to ventricular arrhythmia in patients with a nonischemic cardiomyopathy. This possibility was demonstrated in a study in which three-dimensional intraoperative mapping for intramural sites was performed in six patients undergoing cardiac transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/3\">",
"     3",
"    </a>",
"    ]. Spontaneous or induced ventricular arrhythmia arose primarily in the subendocardium by a focal mechanism, probably from triggered activity arising from either early afterdepolarizations or delayed afterdepolarizations, without evidence of reentry. Although there was evidence of conduction delay and block, these sites were consistently distant from the sites of focal initiation.",
"   </p>",
"   <p>",
"    Myocardial repolarization is altered in congestive heart failure, independent of the etiology of the cardiomyopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/4\">",
"     4",
"    </a>",
"    ]. This is the result of downregulation of the calcium-independent transient outward potassium current and inward rectifier potassium current [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/5\">",
"     5",
"    </a>",
"    ]. The Kv4.3 gene encodes all or part of the outward potassium current; in one series of patients with heart failure, altered transcription of this gene and the ensuing reduction in mRNA were responsible for the decline in the outward potassium current [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/6\">",
"     6",
"    </a>",
"    ]. Another mechanism for altered repolarization is a late sodium current, found in high density in cardiomyocytes of animals with chronic heart failure; this current is characterized by an ultraslow, voltage-independent inactivation and reactivation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The surface ECG may show increased QT dispersion, indicative of spatial heterogeneity in repolarization [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/8\">",
"     8",
"    </a>",
"    ]. Temporal variations in repolarization, manifest as beat to beat fluctuation in the QT interval, have also been observed; the variability increases with worsening functional class [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/9\">",
"     9",
"    </a>",
"    ]. The abnormalities in repolarization may be associated with a potential for polymorphic ventricular tachycardia and ventricular fibrillation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Mechanical factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanical factors which can alter the electrophysiologic properties (electromechanical feedback) of myocardial tissue in HF include an increase in wall stress and left ventricular dilation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. In the normal heart, acute myocardial stretch does not alter transverse or longitudinal conduction velocity but shortens the action potential duration and the membrane refractory period, while increasing spontaneous automaticity and triggered activity [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/12\">",
"     12",
"    </a>",
"    ]. These effects are more pronounced at faster heart rates. One animal model found that these electrophysiologic changes are mediated by activation of the beta adrenergic receptor and an increase in cyclic AMP-mediated potassium currents [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/13\">",
"     13",
"    </a>",
"    ]. In contrast, an animal model of dilated cardiomyopathy noted significant prolongation of refractoriness and action potential duration without a change in conduction times [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/14\">",
"     14",
"    </a>",
"    ]. Additional volume loading resulted in further prolongation of these parameters; volume unloading with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21302?source=see_link\">",
"     nitroprusside",
"    </a>",
"    did not normalize them.",
"   </p>",
"   <p>",
"    Since regions of the heart differ in mechanical function, electromechanical feedback may result in an increase in dispersion of action potential duration and membrane recovery. In addition, electromechanical feedback decreases in magnitude as steady state heart rate increases [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/15\">",
"     15",
"    </a>",
"    ]. These observations have implications in the setting of frequent ventricular premature beats, since the occurrence of short and long intervals from beat to beat may enhance dispersion of recovery.",
"   </p>",
"   <p>",
"    These effects can increase the incidence of arrhythmias. Among 311 patients in the SOLVD (Studies of Left Ventricular Dysfunction) trial, for example, there was a direct correlation between left ventricular end-diastolic volume and the prevalence of ventricular arrhythmia&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Neurohormonal factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure results in the activation of the sympathetic nervous and renin-angiotensin systems in an attempt to preserve homeostasis in the face of decreased cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Markers for sympathetic activation and withdrawal of parasympathetic tone include heart rate, which is increased in HF; heart rate variability, which is reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/19\">",
"     19",
"    </a>",
"    ]; and baroreceptor sensitivity, which is depressed [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32455?source=see_link\">",
"     \"Pathophysiology of heart failure: Neurohumoral adaptations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One study of 142 patients with HF found that depressed baroreceptor receptor sensitivity, but not heart rate variability, was associated with the presence of nonsustained ventricular tachycardia (odds ratio 3.8) and, in the presence of high pulmonary capillary wedge pressure (an indirect index of left ventricular stretch or wall stress), the odds ratio for nonsustained ventricular tachycardia increased to 6.5 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/20\">",
"     20",
"    </a>",
"    ]. This observation suggests a synergistic effect of autonomic system imbalance and left ventricular stretch in predisposing to ventricular arrhythmia.",
"   </p>",
"   <p>",
"    Neurohumoral activation can promote arrhythmia formation via a variety of mechanisms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Catecholamines are arrhythmogenic by virtue of their ability to enhance automaticity, precipitate triggered activity, and alter conduction and refractoriness, which may promote reentry.",
"     </li>",
"     <li>",
"      Angiotensin II can indirectly promote arrhythmia formation via potassium and magnesium loss in the urine. It can also potentiate the effects of the sympathetic nervous system through central or peripheral actions.",
"     </li>",
"     <li>",
"      Both systems may be arrhythmogenic because the associated vasoconstriction alters loading conditions, affecting wall stress and mechanical factors as described above.",
"     </li>",
"     <li>",
"      Idiopathic dilated cardiomyopathy may be associated with a nonhomogeneous distribution of sympathetic fibers; regions with necrosis and dense scar show myocardial denervation, similar to what has been observed after an acute myocardial infarction [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/21\">",
"       21",
"      </a>",
"      ]. This, in turn, may lead to denervation hypersensitivity with increased sensitivity to circulating catecholamines.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, other regions of the myocardium may show an increase in sympathetic innervation, possibly the result of injury-related nerve sprouting. Immunocytochemical staining of tissue from patients with severe heart failure that was due to either an idiopathic cardiomyopathy or a myocardial infarction found regional hyperinnervation, with an increase in sympathetic nerve fibers in the perivascular regions and the periphery of injured myocardium, among those with a history of ventricular tachycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Autoantibodies against beta adrenergic receptors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autoantibodies against beta-1 adrenergic receptors can be detected in up to 50 percent of patients with an idiopathic dilated cardiomyopathy. One subgroup of autoantibodies, directed against the second extracellular domain of the beta-1 adrenergic receptor, exerts sympathomimetic activity [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/23\">",
"     23",
"    </a>",
"    ]. In a report of 104 patients, these autoantibodies were detected in 38 percent of patients and were closely associated with serious ventricular arrhythmias and were independent predictors of sudden death [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/0/19465?source=see_link&amp;anchor=H27#H27\">",
"     \"Causes of dilated cardiomyopathy\", section on 'Autoimmunity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Electrolyte abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with HF often have electrolyte abnormalities, particularly diuretic-induced hypokalemia and hypomagnesemia [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/25\">",
"     25",
"    </a>",
"    ]. In addition, stimulation of beta-2 receptors by circulating epinephrine can transiently lower the plasma potassium concentration by enhancing potassium entry into cells. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/17/5402?source=see_link&amp;anchor=H17666854#H17666854\">",
"     \"Causes of hypokalemia\", section on 'Elevated beta-adrenergic activity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hypokalemia and possibly hypomagnesemia may be directly arrhythmogenic. In the SOLVD trial, for example, non-potassium-sparing diuretic use at baseline was associated with a lower serum concentration of potassium and a higher incidence of arrhythmic death compared to no diuretic use (3.1 versus 1.7 deaths per 100 patient-years) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/26\">",
"     26",
"    </a>",
"    ]. This relationship remained significant after controlling for other factors (relative risk 1.33) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/26\">",
"     26",
"    </a>",
"    ]. Low myocardial cell magnesium concentrations can contribute to abnormal repolarization [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/27\">",
"     27",
"    </a>",
"    ] and low potassium and magnesium may also potentiate the arrhythmogenic effects of catecholamines, digitalis, or antiarrhythmic agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/55/3962?source=see_link\">",
"     \"Use of diuretics in patients with heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether silent or overt, ischemia, through its effects on electrolyte shifts, acidosis, and other mediators, may lead to alteration in the electrophysiologic milieu, including regional alterations in conduction and refractoriness and enhanced automaticity. These alterations may be enhanced by hypokalemia, increased catecholamine levels, digitalis, and antiarrhythmic agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Role in sudden death",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although sudden death is most often the result of a ventricular tachyarrhythmia, the role of an acute coronary event in patients with heart failure is uncertain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16233?source=see_link\">",
"     \"Pathophysiology and etiology of sudden cardiac arrest\"",
"    </a>",
"    .) The prevalence of an acute coronary finding (coronary thrombus, ruptured plaque, or myocardial infarction) and its relationship to SCD was examined in one autopsy study of 171 patients with heart failure [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/28\">",
"     28",
"    </a>",
"    ]. In patients with significant coronary artery disease, an acute coronary finding was found in 54 percent who died suddenly and in 32 percent who died of myocardial failure, although an acute coronary event had not been clinically diagnosed before death. In contrast, an acute coronary finding was uncommon in those without coronary disease, present in 5 percent of those who died suddenly and 10 percent of those who died from myocardial failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The drugs used to treat HF can directly or indirectly precipitate arrhythmia formation. The role of diuretic-induced electrolyte disturbances has already been discussed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Phosphodiesterase inhibitors &ndash; Phosphodiesterase inhibitors are positive inotropic agents that are not currently used in the management of HF. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/37/7769?source=see_link\">",
"       \"Inotropic agents in heart failure due to systolic dysfunction\"",
"      </a>",
"      .) These drugs increase intracellular calcium, which can increase cyclic AMP and precipitate afterdepolarizations, resulting in triggered activity. They can also exacerbate ventricular arrhythmias by inducing ischemia [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/29\">",
"       29",
"      </a>",
"      ]. A number of trials have shown that one such agent,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/18/3366?source=see_link\">",
"       milrinone",
"      </a>",
"      , increased the frequency of all forms of spontaneous arrhythmia [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/30-32\">",
"       30-32",
"      </a>",
"      ] and, in a long term survival trial (PROMISE), was associated with a 20 percent excess in mortality compared to placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Sympathomimetic drugs &ndash; Studies with the sympathomimetic agents",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/34\">",
"       34",
"      </a>",
"      ],",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/57/20372?source=see_link\">",
"       pirbuterol",
"      </a>",
"      , and salbutamol have shown an increased frequency of ventricular arrhythmias",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      increased mortality.",
"      <br/>",
"      <br/>",
"      The use of sympathomimetic drugs is also associated with an increased incidence of hospitalization for arrhythmia, especially atrial fibrillation, ventricular tachycardia, and ventricular fibrillation. In one study of 149 patients with heart failure who were admitted for arrhythmia, 22 percent were receiving an inhaled or systemic sympathomimetic (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/55/12151?source=see_link\">",
"       terbutaline",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/61/16344?source=see_link\">",
"       albuterol",
"      </a>",
"      ) compared to their use in 11 percent of matched control patients not admitted for arrhythmia [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/35\">",
"       35",
"      </a>",
"      ]. The use of any sympathomimetic drug was associated with an increased risk of admission for arrhythmia (adjusted odds ratio 4.0), while the adjusted odds ratio was 15.7 for the use of a systemic sympathomimetic agent.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"       Digoxin",
"      </a>",
"      &ndash; There have been conflicting data on the effect of digoxin on the frequency and clinical significance of arrhythmias in HF. Two relatively large and well done studies found that digoxin did not significantly affect the frequency of ventricular arrhythmias in patients with congestive heart failure [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/32,36\">",
"       32,36",
"      </a>",
"      ]. On the other hand, two retrospective studies in patients with HF after acute myocardial infarction reported an excess mortality in patients who had complex ventricular arrhythmias who were treated with digitalis&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/37,38\">",
"       37,38",
"      </a>",
"      ]; however, other reports did not confirm this increase in risk in post-MI patients [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/39,40\">",
"       39,40",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The largest trial evaluating the efficacy of digoxin in HF, the DIG trial, randomly assigned approximately 6800 patients with HF to digoxin or placebo; all patients were also treated with an ACE inhibitor and, if necessary, a diuretic [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14615/abstract/41\">",
"       41",
"      </a>",
"      ]. Digoxin was associated with an increase in non-HF cardiac mortality that included a trend towards increased mortality from arrhythmia. This trend counterbalanced the fewer deaths from progressive heart failure in patients treated with digoxin, leading to no effect on overall patient survival. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/4/18504?source=see_link\">",
"       \"Use of digoxin in heart failure due to systolic dysfunction\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2333374\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Both atrial and ventricular arrhythmias are common in patients with heart failure (HF) and cardiomyopathy and can contribute to symptoms, morbidity, and mortality. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Extensive myocardial damage and fibrosis or the loss of cell-to-cell coupling in patients with dilated cardiomyopathy provides the proper substrate for reentry, the mechanism thought to be responsible for most ventricular arrhythmias in persons with HF. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Underlying structural disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mechanical factors which can alter the electrophysiologic properties (electromechanical feedback) of myocardial tissue in HF include an increase in wall stress and left ventricular dilation. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Mechanical factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neurohumoral activation can promote arrhythmia formation via a variety of mechanisms, including enhanced automaticity, electrolyte disturbances, vasoconstriction, and fibrosis. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Neurohormonal factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with HF often have electrolyte abnormalities, particularly diuretic-induced hypokalemia and hypomagnesemia, which may be directly arrhythmogenic. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Electrolyte abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some of the medications used to treat HF, such as phosphodiesterase inhibitors, sympathomimetic agents, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"       digoxin",
"      </a>",
"      , may directly or indirectly precipitate arrhythmia formation. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Drugs'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/1\">",
"      Francis GS. Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis. Am J Cardiol 1986; 57:3B.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/2\">",
"      Wu TJ, Ong JJ, Hwang C, et al. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. J Am Coll Cardiol 1998; 32:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/3\">",
"      Pogwizd SM, McKenzie JP, Cain ME. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation 1998; 98:2404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/4\">",
"      Tomaselli GF, Beuckelmann DJ, Calkins HG, et al. Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation 1994; 90:2534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/5\">",
"      Beuckelmann DJ, N&auml;bauer M, Erdmann E. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993; 73:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/6\">",
"      K&auml;&auml;b S, Dixon J, Duc J, et al. Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 1998; 98:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/7\">",
"      Maltsev VA, Sabbah HN, Higgins RS, et al. Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 1998; 98:2545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/8\">",
"      Grimm W, Steder U, Menz V, et al. QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy. Am J Cardiol 1996; 78:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/9\">",
"      Berger RD, Kasper EK, Baughman KL, et al. Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997; 96:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/10\">",
"      White CW, Mirro MJ, Lund DD, et al. Alterations in ventricular excitability in conscious dogs during development of chronic heart failure. Am J Physiol 1986; 250:H1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/11\">",
"      Dean JW, Lab MJ. Arrhythmia in heart failure: role of mechanically induced changes in electrophysiology. Lancet 1989; 1:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/12\">",
"      Reiter MJ, Landers M, Zetelaki Z, et al. Electrophysiological effects of acute dilatation in the isolated rabbit heart: cycle length-dependent effects on ventricular refractoriness and conduction velocity. Circulation 1997; 96:4050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/13\">",
"      Lerman BB, Engelstein ED, Burkhoff D. Mechanoelectrical feedback: role of beta-adrenergic receptor activation in mediating load-dependent shortening of ventricular action potential and refractoriness. Circulation 2001; 104:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/14\">",
"      Zhu WX, Johnson SB, Brandt R, et al. Impact of volume loading and load reduction on ventricular refractoriness and conduction properties in canine congestive heart failure. J Am Coll Cardiol 1997; 30:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/15\">",
"      Horner SM, Dick DJ, Murphy CF, Lab MJ. Cycle length dependence of the electrophysiological effects of increased load on the myocardium. Circulation 1996; 94:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/16\">",
"      Koilpillai C, Qui&ntilde;ones MA, Greenberg B, et al. Relation of ventricular size and function to heart failure status and ventricular dysrhythmia in patients with severe left ventricular dysfunction. Am J Cardiol 1996; 77:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/17\">",
"      Cohn JN, Rector TS. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol 1988; 62:25A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/18\">",
"      Packer M, Gottlieb SS, Blum MA. Immediate and long-term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure. Am J Med 1987; 82:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/19\">",
"      Casolo G, Balli E, Taddei T, et al. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol 1989; 64:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/20\">",
"      Mortara A, La Rovere MT, Pinna GD, et al. Depressed arterial baroreflex sensitivity and not reduced heart rate variability identifies patients with chronic heart failure and nonsustained ventricular tachycardia: the effect of high ventricular filling pressure. Am Heart J 1997; 134:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/21\">",
"      Schofer J, Spielmann R, Schuchert A, et al. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988; 12:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/22\">",
"      Cao JM, Fishbein MC, Han JB, et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 2000; 101:1960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/23\">",
"      Chiale PA, Ferrari I, Mahler E, et al. Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 2001; 103:1765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/24\">",
"      Iwata M, Yoshikawa T, Baba A, et al. Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2001; 37:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/25\">",
"      Gottlieb SS, Baruch L, Kukin ML, et al. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol 1990; 16:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/26\">",
"      Cooper HA, Dries DL, Davis CE, et al. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999; 100:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/27\">",
"      Haigney MC, Wei S, K&auml;&auml;b S, et al. Loss of cardiac magnesium in experimental heart failure prolongs and destabilizes repolarization in dogs. J Am Coll Cardiol 1998; 31:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/28\">",
"      Uretsky BF, Thygesen K, Armstrong PW, et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation 2000; 102:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/29\">",
"      Stambler BS, Wood MA, Ellenbogen KA. Sudden death in patients with congestive heart failure: future directions. Pacing Clin Electrophysiol 1992; 15:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/30\">",
"      Holmes JR, Kubo SH, Cody RJ, Kligfield P. Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias. Am Heart J 1985; 110:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/31\">",
"      Anderson JL, Askins JC, Gilbert EM, et al. Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone. Am Heart J 1986; 111:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/32\">",
"      DiBianco R, Shabetai R, Kostuk W, et al. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989; 320:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/33\">",
"      Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991; 325:1468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/34\">",
"      Dies F, Krell MJ, Whitlow P, et al. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation 1986; 74(Suppl II):II.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/35\">",
"      Bouvy ML, Heerdink ER, De Bruin ML, et al. Use of sympathomimetic drugs leads to increased risk of hospitalization for arrhythmias in patients with congestive heart failure. Arch Intern Med 2000; 160:2477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/36\">",
"      Gradman A, Deedwania P, Cody R, et al. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol 1989; 14:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/37\">",
"      Moss AJ, Davis HT, Conard DL, et al. Digitalis-associated cardiac mortality after myocardial infarction. Circulation 1981; 64:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/38\">",
"      Bigger JT Jr, Fleiss JL, Rolnitzky LM, et al. Effect of digitalis treatment on survival after acute myocardial infarction. Am J Cardiol 1985; 55:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/39\">",
"      Ryan TJ, Bailey KR, McCabe CH, et al. The effects of digitalis on survival in high-risk patients with coronary artery disease. The Coronary Artery Surgery Study (CASS). Circulation 1983; 67:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/40\">",
"      Muller JE, Turi ZG, Stone PH, et al. Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study. N Engl J Med 1986; 314:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14615/abstract/41\">",
"      The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997; 336:525.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3453 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-199.231.185.123-2EEB765D3A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14615=[""].join("\n");
var outline_f14_17_14615=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2333374\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Underlying structural disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Mechanical factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Neurohormonal factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Autoantibodies against beta adrenergic receptors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Electrolyte abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ischemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Role in sudden death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2333374\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24042?source=related_link\">",
"      Atrial fibrillation in patients with heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/0/19465?source=related_link\">",
"      Causes of dilated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/17/5402?source=related_link\">",
"      Causes of hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/37/7769?source=related_link\">",
"      Inotropic agents in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/54/16233?source=related_link\">",
"      Pathophysiology and etiology of sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32455?source=related_link\">",
"      Pathophysiology of heart failure: Neurohumoral adaptations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/62/42984?source=related_link\">",
"      Reentry and the development of cardiac arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/4/18504?source=related_link\">",
"      Use of digoxin in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/55/3962?source=related_link\">",
"      Use of diuretics in patients with heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/47/21241?source=related_link\">",
"      Ventricular arrhythmias in heart failure and cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_17_14616="Radial artery catheterization techniques";
var content_f14_17_14616=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F74903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F74903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    Radial artery catheterization techniques",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 703px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     Separate-guidewire approach*:",
"    </strong>",
"    The nondominant hand palpates the artery while the dominant hand manipulates the catheter, which is inserted and advanced slowly until pulsatile blood return is observed. The catheter is advanced slightly, ensuring the outer catheter has also entered the lumen. Care must be taken to avoid puncturing the posterior wall of the vessel when advancing the catheter. The nondominant hand then stabilizes the catheter while the dominant hand removes the needle from the intravascular catheter. If pulsatile blood return is observed after the needle is removed, the guidewire is advanced until its tip is beyond the distal end of the catheter. Finally, the catheter is advanced into the artery over the guidewire and the guidewire is removed.",
"    <br>",
"     <strong>",
"      Integral-guidewire approach*:",
"     </strong>",
"     The guidewire of this specialized device is integrated with the needle and catheter. The nondominant hand palpates the artery, while the dominant hand manipulates the needle-guidewire-catheter unit, which is inserted and advanced slowly until pulsatile blood return is observed. The nondominant hand then stabilizes the needle-guidewire-catheter unit, while the dominant hand advances the guidewire tab to push the wire into and through the needle and catheter. The outer catheter is advanced over the needle and wire into the artery. Finally, the needle-guidewire unit is removed.",
"     <div class=\"footnotes\">",
"      * For illustration purposes, full barrier precautions are not pictured.",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14616=[""].join("\n");
var outline_f14_17_14616=null;
var title_f14_17_14617="Natural history, screening, and management of rheumatic heart disease";
var content_f14_17_14617=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Natural history, screening, and management of rheumatic heart disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/17/14617/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/17/14617/contributors\">",
"     Bongani Mayosi, MBChB, PhD, FCP(SA)",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/17/14617/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/17/14617/contributors\">",
"     William H Gaasch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/17/14617/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/17/14617/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/17/14617/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 28, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H16376453\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rheumatic heart disease remains a major cause of cardiovascular disease in developing nations, although the prevalence of rheumatic heart disease (RHD) has declined sharply in industrialized countries during the last century [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the epidemiology, natural history, screening, and management of RHD. The epidemiology, pathogenesis, diagnosis, treatment, and prevention of acute rheumatic fever are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8327?source=see_link\">",
"     \"Epidemiology and pathogenesis of acute rheumatic fever\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute rheumatic fever\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44070?source=see_link\">",
"     \"Treatment and prevention of acute rheumatic fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7988558\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;RHD is by far the most important form of acquired heart disease in children and young adults living in developing countries (which are inhabited by 80 percent of the world&rsquo;s population); RHD accounts for about a quarter of all patients with heart failure in endemic countries [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    RHD is a disease of poverty. The impact of socioeconomic status is illustrated by a study from Kinshasa where the prevalence based on clinical examination was 22.2 per 1000 among children who lived in slums but only 4 per 1000 among children attending the city schools [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/4\">",
"     4",
"    </a>",
"    ]. The importance of socioeconomic factors is further underscored by the virtual disappearance of RHD in the industrialized countries since the mid-twentieth century, which started well before the introduction of penicillin. In contrast, RHD is still endemic in Africa, Asia, South America, and developing communities of Australasia [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Echocardiographic diagnostic criteria have revealed high prevalence rates in developing countries, for example, 21.5 per 1000 in Cambodia, 30.4 per 1000 in Mozambique, 48 per 1000 in Nicaragua, and 62 per 1000 in Kenya, providing an average point prevalence of 40 per 1000 in school-aged children [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. The prevalence of RHD is 20 per 1000 among young adults (20 to 35 years) in Nicaragua [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/6\">",
"     6",
"    </a>",
"    ]. Based on these data, it is estimated that there are 62 to 78 million individuals who have RHD worldwide, a disease burden that could potentially result in 1.4 million deaths per year from RHD and its complications [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The disease causes symptomatic valvular heart disease in children who are younger than five years of age in Africa and Asia, and the burden of disease rises with age. In South Africa, the incidence of heart failure due to RHD increases from 30 per 100,000 per year in the 14 to 19 year age group, to over 53 per 100,000 per year in the elderly, providing an average incidence of 23 per 100,000 per year [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/8\">",
"     8",
"    </a>",
"    ]. These rates are in contrast to the incidence of rheumatic fever in developed countries of",
"    <span class=\"nowrap\">",
"     &lt;1/100,000",
"    </span>",
"    of the population per year [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512855\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;RHD includes a spectrum of lesions from pericarditis, myocarditis, and valvulitis during acute rheumatic fever (ARF), to chronic valvular lesions that evolve over years following one or more episodes of acute rheumatic fever.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16376507\">",
"    <span class=\"h2\">",
"     Acute rheumatic fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute rheumatic fever causes pancarditis, affecting the pericardium, epicardium, myocardium, and endocardium. Other clinical manifestations of ARF are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute rheumatic fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Valvulitis is frequently present. Valvulitis may be suspected by auscultatory findings although valvular regurgitation is sometimes inaudible [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/10\">",
"     10",
"    </a>",
"    ]. Echocardiography findings include leaflet thickening, verrucous vegetations, mitral valve prolapse, and evidence of mitral",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    aortic regurgitation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/10\">",
"     10",
"    </a>",
"    ]. However, Doppler identification of mitral",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    aortic regurgitation alone is not diagnostic of rheumatic valvulitis. Physiologic valve regurgitation (trace to mild mitral regurgitation or trace aortic regurgitation) is common in normal individuals. In addition, valve regurgitation may be observed with other febrile illnesses such as viral myocarditis.",
"   </p>",
"   <p>",
"    Mitral regurgitation is the most common early valvular manifestation and may be accompanied by aortic regurgitation; isolated aortic regurgitation is less common [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Mitral regurgitation is often caused by mitral valve prolapse. Mitral valve prolapse in ARF involves predominantly the anterior leaflet with minimal leaflet redundancy, in contrast to myxomatous disease which more commonly involves the posterior leaflet and is associated with prominent leaflet redundancy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/10,13\">",
"     10,13",
"    </a>",
"    ]. Leaflet prolapse appears to be due to annular dilation and chordal elongation. Aortic or mitral stenosis is unusual at presentation; these are typically late manifestations due to scarring and calcification of damaged valves.",
"   </p>",
"   <p>",
"    Left ventricular dilation and heart failure have been observed, predominantly in patients with severe valve disease. Although myocarditis is common in autopsy cases, the main cause of left ventricular dilation and heart failure appears to be severe mitral regurgitation with or without aortic regurgitation, as suggested by prompt reduction in left ventricular dimensions and preserved systolic function following valve surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/10\">",
"     10",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    Electrocardiographic findings may demonstrate any degree of heart block, including atrioventricular dissociation. Chest radiography may demonstrate cardiomegaly. Echocardiography permits serial assessment of valve lesions, pericardial effusion, ventricular and atrial dilatation, and ventricular function [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment and prevention of acute rheumatic fever is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44070?source=see_link\">",
"     \"Treatment and prevention of acute rheumatic fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512862\">",
"    <span class=\"h2\">",
"     Transition from acute to chronic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Progressive valvular disease commonly develops in the years following one or more episodes of acute rheumatic fever, as illustrated by the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective study of children with acute rheumatic fever in the modern era in Brazil found that 72 percent of the 258 subjects developed chronic valvular disease, and 16 percent progressed to severe aortic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      mitral disease [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Frequent development of chronic valvular disease was also observed in the largest prospective study of the natural history of acute rheumatic fever in the preantibiotic era [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/16\">",
"       16",
"      </a>",
"      ]. Twenty-year follow-up by clinical examination of this North American series of 1000 children and adolescents yielded the following observations:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      65 percent of patients had clinical evidence of valvular heart disease after recovery from the initial episode of rheumatic fever. By the end of 20 years of follow-up, the signs of rheumatic valvular disease had disappeared in 17 percent of these patients.",
"     </li>",
"     <li>",
"      The remaining 35 percent of patients recovered from their initial attack without detectable valvular heart disease. However, by the end of 20 years of follow-up, 44 percent of these patients had overt signs of valvular heart disease.",
"     </li>",
"     <li>",
"      In this preantibiotic series, the mortality rate of acute rheumatic fever was 1.5 percent per year, with recurrent rheumatic fever and heart failure together accounting for 80 percent of fatalities and bacterial endocarditis for an additional 10 percent.",
"     </li>",
"     <li>",
"      Pure mitral stenosis developed in 12 percent of patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23709418\">",
"    <span class=\"h2\">",
"     Chronic valve disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In rheumatic heart disease, the mitral valve is involved in nearly all cases, the aortic valve is involved in about 20 to 30 percent. The tricuspid valve is commonly affected but is frequently subclinical until surgery is required. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24385710\">",
"    <span class=\"h3\">",
"     Stages of disease and relationship to age",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence and pattern of mitral valve pathology in RHD varies according to age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/8\">",
"     8",
"    </a>",
"    ]. Younger patients under the age of 30 years present predominantly with pure mitral regurgitation, whereas middle aged adult patients develop mitral stenosis from the third decade, with mixed mitral valve disease becoming more dominant in older patients.",
"   </p>",
"   <p>",
"    In the above preantibiotic era series, a characteristic blowing diastolic murmur of aortic regurgitation was observed in 19 percent of children with a first episode of rheumatic fever, and subsequently developed in a similar proportion of untreated patients followed over time, such that a total of 38 percent developed aortic regurgitation over the course of 20 years [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/16\">",
"     16",
"    </a>",
"    ]. Isolated aortic regurgitation was observed in only 3 percent of cases of rheumatic valve disease, with the remainder having coexistent mitral valve disease.",
"   </p>",
"   <p>",
"    Rheumatic aortic valve stenosis occurs in patients with concomitant or prior evidence of aortic regurgitation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/17\">",
"     17",
"    </a>",
"    ]. Rheumatic aortic stenosis generally develops over a period of decades and pure rheumatic aortic stenosis is rare under the age of 30. Concomitant bicuspid aortic valve has been suspected in some cases [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/17\">",
"     17",
"    </a>",
"    ], but early stenosis can occur with a trileaflet valve [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512869\">",
"    <span class=\"h3\">",
"     Mitral stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural history of mitral stenosis (MS) varies across geographical areas [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/1\">",
"     1",
"    </a>",
"    ]. In North America, for example, it is most commonly a slowly progressive disease, with a latency period as long as 20 to 40 years between the initial infection and the onset of clinical symptoms. In developing countries, on the other hand, mitral stenosis progresses much more rapidly, and may lead to symptoms in patients who are less than five years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Survival is greater than 80 percent at 10 years for patients who are asymptomatic or minimally symptomatic (New York Heart Association (NYHA) functional class I or II) (",
"    <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"     table 1",
"    </a>",
"    ) at time of diagnosis; 60 percent of such patients may not experience any progression of symptoms over this time frame [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/1\">",
"     1",
"    </a>",
"    ]. Once limiting symptoms (NYHA functional class III or IV) develop, however, survival without intervention predictably worsens, and has been estimated at 0 to 15 percent over the ensuing 10 years. Mean survival time falls to less than three years if severe pulmonary hypertension has intervened. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/29/18901?source=see_link\">",
"     \"Natural history of mitral stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among the acquired heart valve lesions, MS is associated with the highest risk of systemic thromboembolism. The risk increases markedly following the onset of AF, and is considerably higher for patients with MS compared to those with isolated mitral regurgitation. Patients who suffer a first embolus are at increased risk for repeat embolization, particularly over the ensuing six months. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/18/13610?source=see_link&amp;anchor=H16#H16\">",
"     \"Pathophysiology, clinical features, and evaluation of mitral stenosis\", section on 'Thromboembolism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512876\">",
"    <span class=\"h3\">",
"     Mitral regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The volume load of chronic mitral regurgitation may be well tolerated for several years. Indeed, the reduced left ventricular afterload associated with mitral regurgitation may obscure recognition of left ventricular contractile dysfunction until relatively late in the natural history [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36901?source=see_link\">",
"     \"Pathophysiology and stages of chronic mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512883\">",
"    <span class=\"h3\">",
"     Mixed mitral stenosis/regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with rheumatic mitral valve disease have important stenotic and regurgitant components owing to commissural fusion and the &ldquo;fish mouth&rdquo; deformity imparted by the pathological process. Pathologically, the valves are more deformed than with pure regurgitant or pure stenotic lesions. One lesion may predominate, or the components may be more closely balanced, creating a hybrid natural history [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512890\">",
"    <span class=\"h3\">",
"     Aortic regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with chronic, severe aortic regurgitation usually have a long, yet variable, compensated phase, characterized by an increase in left ventricular end-diastolic volume and a combination of both eccentric and concentric hypertrophy associated with increased chamber compliance. Asymptomatic patients with left ventricular dysfunction, however, develop symptoms (angina, heart failure) at a rate of greater than 25 percent per year, and symptomatic patients with severe aortic regurgitation have an expected mortality that exceeds 10 percent per year [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/29/25050?source=see_link\">",
"     \"Course and management of chronic aortic regurgitation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512897\">",
"    <span class=\"h3\">",
"     Aortic stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic stenosis generally progresses gradually over years, although the clinical course is variable. Mortality dramatically increases after the development of symptoms. Average survival without valve replacement after the onset of angina, syncope, or heart failure is only two to three years. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=see_link\">",
"     \"Indications for valve replacement in aortic stenosis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30551?source=see_link\">",
"     \"Natural history of aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512904\">",
"    <span class=\"h3\">",
"     Tricuspid valve disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Functional tricuspid incompetence occurs with right heart failure because dilatation of the right ventricle stretches the valve ring. Organic tricuspid incompetence is a result of shortening and thickening of the tricuspid leaflets so that they are imperfectly sealed during ventricular systole. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/9/149?source=see_link\">",
"     \"Etiology, clinical features, and evaluation of tricuspid regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The normal tricuspid valve area is greater than 7 cm2, and reduction of this orifice size to less than 1.5 cm2 results in hemodynamic significant stenosis. Rheumatic tricuspid stenosis is almost invariably associated with mitral valve disease. Tricuspid stenosis without regurgitation is a relatively uncommon condition, and since the diagnosis is difficult to make on physical examination, it is often missed [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/27/5558?source=see_link&amp;anchor=H4#H4\">",
"     \"Tricuspid stenosis: Clinical features, diagnosis, and percutaneous tricuspid balloon valvotomy\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512933\">",
"    <span class=\"h1\">",
"     SCREENING IN ENDEMIC SETTINGS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512941\">",
"    <span class=\"h2\">",
"     Rationale",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening school children and young adults in endemic settings for RHD is appropriate given the significant disease burden [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Screening has utility since the disease has an initial latent stage that is detectable by simple, accurate testing and is amenable to treatment that improves prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/5-7,23\">",
"     5-7,23",
"    </a>",
"    ]. There are large numbers of presymptomatic cases with typical auscultatory and echocardiographic abnormalities, and portable echocardiography is a sensitive tool for screening. Secondary prophylaxis reduces recurrent rheumatic fever episodes and frequency and duration of hospitalization.",
"   </p>",
"   <p>",
"    There is no evidence to suggest that treatment alters the natural history once clinically overt valve damage and heart failure have occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/19,24\">",
"     19,24",
"    </a>",
"    ]. Screening is warranted for detecting individuals with early subclinical disease who would benefit from prophylaxis and individuals with severe subclinical valve disease who would benefit from monitoring and intervention screening [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44070?source=see_link\">",
"     \"Treatment and prevention of acute rheumatic fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512948\">",
"    <span class=\"h2\">",
"     Types of screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening for RHD involves eliciting a history of acute rheumatic fever, clinical cardiac auscultation, and echocardiography. An individual with a typical cardiac valvular abnormality with a history of acute rheumatic fever, regardless of severity, represents a definite case of RHD. A useful classification system for cases without a history of acute rheumatic fever that are identified by combined echocardiographic and clinical screening is shown in the following table (",
"    <a class=\"graphic graphic_table graphicRef66581 \" href=\"UTD.htm?24/13/24795\">",
"     table 2",
"    </a>",
"    ). If a definite history of acute rheumatic fever is present, the individual should be enrolled in a register-based secondary prophylaxis program according to the current guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44070?source=see_link&amp;anchor=H8#H8\">",
"     \"Treatment and prevention of acute rheumatic fever\", section on 'Secondary prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are two screening approaches that have been applied to rheumatic valve disease in high-risk communities in individuals with or without a history of rheumatic fever: clinical cardiac auscultation followed by echocardiographic confirmation in patients with a significant murmur; or portable echocardiography for all, followed by clinical examination of abnormal cases. However, cardiac auscultation has been shown to lack sensitivity and specificity for detection of valve pathology by echocardiography, leaving many subclinical cases of RHD undiagnosed [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/26\">",
"     26",
"    </a>",
"    ].",
"    <strong>",
"    </strong>",
"    Therefore, we favor the later approach for screening.",
"   </p>",
"   <p>",
"    It is not yet proven that penicillin prophylaxis for children with subclinical rheumatic valve lesions (ie, probable or possible RHD) is the best option in clinical practice. However, antibiotic prophylaxis is recommended in endemic areas in those children with &ldquo;significant subclinical RHD&rdquo; (ie, probable RHD in the following table) (",
"    <a class=\"graphic graphic_table graphicRef66581 \" href=\"UTD.htm?24/13/24795\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/1\">",
"     1",
"    </a>",
"    ]. Research into the risks and benefits of including all children with subclinical (ie, probable or possible) rheumatic heart lesions in follow-up prevention programs are required to determine the best strategy for RHD prevention [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The selection of echocardiographic criteria for diagnosis of RHD affects the rate of detection of disease. According to World Health Organization (WHO) criteria, &ldquo;significant&rdquo; valve lesions are at least a &ldquo;very mild&rdquo; regurgitant jet defined as &ldquo;more than 1.0 cm, localized immediately above or below the valve, throughout systole at the mitral valve or diastole at the aortic valve,&rdquo; and no morphologic criteria are applied [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/1\">",
"     1",
"    </a>",
"    ]. A study compared rates of detection of subclinical RHD using WHO criteria versus combined valvular regurgitation plus morphologic criteria (at least two of leaflet restriction, subvalvular thickening and valvular thickening) in 2710 school children in Mozambique [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/27\">",
"     27",
"    </a>",
"    ]. Definite RHD was diagnosed in 7.8 percent using WHO criteria and 30.4 using combined criteria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512964\">",
"    <span class=\"h2\">",
"     Screening summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening is recommended for children and young adults from communities and countries where RHD is endemic. We recommend the following sequence for screening: taking a history for prior acute rheumatic fever, performing echocardiography in all, and then clinical cardiac evaluation of cases with abnormal echocardiography. Although there are no guidelines for the timing and frequency of screening, the evidence on the natural history of RHD suggests that at least two echocardiography-based screening tests are indicated: one before age 18 and another by 35 years of age. Cases of probable or possible RHD require a repeat evaluation within a year to confirm the diagnosis prior to embarking upon long-term prophylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512972\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7989029\">",
"    <span class=\"h2\">",
"     Minimizing disease progression",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is clear evidence that secondary prophylaxis with penicillin reduces streptococcal infections, recurrent attacks of acute rheumatic fever, and frequency and duration of hospitalization in patients with acute rheumatic fever and RHD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44070?source=see_link&amp;anchor=H8#H8\">",
"     \"Treatment and prevention of acute rheumatic fever\", section on 'Secondary prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As stated in the WHO guidelines for secondary prophylaxis in patients with RHD, patients with mild carditis (eg, mild mitral regurgitation or healed carditis) should receive secondary prophylaxis for 10 years after the last attack or at least until 25 years of age (whichever is longer) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/1\">",
"     1",
"    </a>",
"    ]. Patients with more severe valvular damage (eg, causing heart failure), or after valve surgery, should receive lifelong secondary prophylaxis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7989068\">",
"    <span class=\"h2\">",
"     Valve disease",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512979\">",
"    <span class=\"h3\">",
"     Management of mitral regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild rheumatic mitral regurgitation is usually well tolerated and the patient often remains asymptomatic for years, so these patients should be seen annually. Patients with moderate MR should be seen and undergo echocardiography yearly or sooner if symptoms occur. Patients with severe mitral regurgitation (MR) should be seen at least every 6 to 12 months to monitor for the development of symptoms by clinical examination and left ventricular systolic dysfunction by echocardiography. Symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    signs of left ventricular systolic dysfunction (defined by an ejection fraction &lt;0.60,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    an end-systolic dimension &ge;4.0 or 4.5 cm) are indications for surgery. Symptomatic status, ventricular functional status, and the likelihood of valve repair versus replacement, all affect the timing of valve surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33593?source=see_link\">",
"     \"Overview of the management of chronic mitral regurgitation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25096?source=see_link\">",
"     \"Indications for corrective surgery in severe chronic primary mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rheumatic disease causes progressive fibrotic thickening of the mitral leaflets and scarring of chordal structures, which limits the durability of mitral valve repair. In young populations with rheumatic mitral regurgitation, the possibility of repair may be high, but the long-term durability of repair is lower than for repair of degenerative mitral disease because of progressive rheumatic fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. Nevertheless, repair produces reasonable outcomes in patients with rheumatic mitral regurgitation as illustrated by various series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study from France of 951 patients with RHD undergoing mitral valve repair from 1970 to 1994, in-hospital mortality was 2 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/29\">",
"       29",
"      </a>",
"      ]. Actuarial survival was 89 percent at 10 years and 82 percent at 20 years. Freedom from reoperation was 82 percent at 10 years and 55 percent at 20 years. Most (83 percent) of reoperations were required due to progressive mitral valve fibrosis. &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      In a study from India of 898 patients with RHD undergoing mitral valve repair from 1998 to 2003, early mortality was 3.6 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/30\">",
"       30",
"      </a>",
"      ]. At 10 years, actuarial survival was 92 percent, and re-operation free survival was 82 percent. However, freedom from moderate or severe MR was only 32 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Data on comparative outcomes for mitral valve repair versus replacement are limited to observational series. However, available data suggest that outcomes following repair are at least as good as those following replacement as illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a series from South Africa and Portugal of patients with RHD (most of whom had predominant mitral regurgitation), 241 underwent mitral valve repair from 1980 to 1984, 386 underwent mechanical mitral valve replacement from 1980 to 1984, and 289 underwent bioprosthetic mitral valve replacement from 1976 to 1980 [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Actuarial survival at five years was higher for valvuloplasty than for mechanical or bioprosthetic valve replacement (90 versus 76 and 62 percent).",
"     </li>",
"     <li>",
"      Reoperation after mitral repair (4.3 percent per year) was similar to that after bioprosthetic replacement (6.7 percent per year), but greater than that after mechanical replacement (1.5 percent per year).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A series from South Korea of RHD patients undergoing mitral surgery from 1997 to 2007 compared 122 undergoing valve repair with 418 patients undergoing valve replacement [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The 10-year survival rates were similar in the repair and replacement groups (86 and 85 percent).",
"     </li>",
"     <li>",
"      The 10-year freedom from reoperation rates were also similar (97 and 94 percent, respectively).",
"     </li>",
"     <li>",
"      However, the treatment groups had significant baseline differences: the repair group was younger, more likely to have predominant mitral regurgitation, and less likely to have mitral stenosis, atrial fibrillation, significant tricuspid regurgitation, or pulmonary hypertension.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Mitral repair appears to be associated with similar or higher rates of reoperation as compared to valve replacement [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. However mortality following reoperation in those originally undergoing repair may be lower than in those originally undergoing replacement (eg, none in the repair group versus 12.4 percent in the bioprosthetic group and 11 percent in the mechanical group in the larger series above [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/31\">",
"     31",
"    </a>",
"    ]).",
"   </p>",
"   <p>",
"    One major advantage of mitral valve repair over replacement is avoidance of the need for and the risks associated with anticoagulation, especially in populations with significant barriers to compliance and limited access to monitoring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512986\">",
"    <span class=\"h3\">",
"     Management of mitral stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monitoring of patients with mitral stenosis is discussed in detail separately. The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association valvular disease guidelines recommend echocardiography to assess pulmonary artery pressure every three to five years in those with mild MS, every one to two years in those with moderate MS, and every year in asymptomatic severe MS, and sooner if symptoms develop. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link&amp;anchor=H2#H2\">",
"     \"Medical management and indications for intervention in mitral stenosis\", section on 'Evaluation and follow-up'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Since MS is a mechanical disorder, the patient with moderate or severe MS should be referred for evaluation for valvuloplasty or surgery as soon as symptoms develop. Patients with moderate or severe MS who present with pulmonary edema without another precipitating cause should be stabilized medically and referred immediately for evaluation for valvuloplasty or surgery. Since evidence suggests that the presence of pulmonary hypertension substantially increases operative risk, surgery should be contemplated in patients who develop asymptomatic pulmonary hypertension (pulmonary artery systolic pressure &gt;50 mmHg at rest). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link&amp;anchor=H18#H18\">",
"     \"Medical management and indications for intervention in mitral stenosis\", section on 'Indications for intervention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptoms may be precipitated by the following factors:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Intercurrent infection",
"     </li>",
"     <li>",
"      Onset of atrial fibrillation",
"     </li>",
"     <li>",
"      Pregnancy",
"     </li>",
"     <li>",
"      Thyrotoxicosis",
"     </li>",
"     <li>",
"      Pulmonary embolism",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to rule out these factors as successful treatment may relieve the symptoms of effort intolerance.",
"   </p>",
"   <p>",
"    The late stages of uncorrected, severe mitral stenosis may be complicated by the development of pulmonary hypertension, and by failure of the right side of the heart, with edema and ascites. Tricuspid regurgitation commonly coexists and is more often secondary to right ventricular dilatation, than to primary rheumatic involvement. (See",
"    <a class=\"local\" href=\"#H10513025\">",
"     'Management of tricuspid valve disease'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6450255\">",
"    <span class=\"h4\">",
"     Atrial fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with mitral stenosis are particularly susceptible to the development of atrial fibrillation (AF). Although episodic and paroxysmal at first, AF tends to become persistent over time. With the onset of AF, there is an abrupt loss of the atrial contribution to ventricular filling and as much as a 30 percent reduction in cardiac output and generally a rapid ventricular rate with associated shortened diastolic filling time. These changes may cause an abrupt increase in left atrial pressure, and prompt therapy is often required. In addition, there is a substantial risk of thromboembolism. Management of these issues is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link&amp;anchor=H13#H13\">",
"     \"Medical management and indications for intervention in mitral stenosis\", section on 'Management of AF'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=see_link\">",
"     \"Overview of atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6450263\">",
"    <span class=\"h4\">",
"     Thromboembolism prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with mitral stenosis at highest risk for embolic events are those with paroxysmal or persistent AF, left atrial thrombus, or a history of prior embolus. Treatment to reduce the risk of thromboembolism is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=see_link&amp;anchor=H10#H10\">",
"     \"Medical management and indications for intervention in mitral stenosis\", section on 'Prevention of thromboembolism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512993\">",
"    <span class=\"h3\">",
"     Management of mixed mitral disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural history of concomitant mitral stenosis and mitral regurgitation is worse than for isolated regurgitation. Only two-thirds of untreated patients with mixed mitral disease are expected to be alive at five years, and only one-third at 10 years. Prosthetic valve replacement is required when symptoms are present and there is mixed moderate stenosis and moderate regurgitation, even though either lesion in isolation might not be considered &ldquo;severe.&rdquo;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10513001\">",
"    <span class=\"h3\">",
"     Management of aortic regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the rate of progression to symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    systolic dysfunction due to chronic AR is slow, these patients should be expectantly followed. Recommended frequency of monitoring varies with severity of AR and LV chamber dimensions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/29/25050?source=see_link&amp;anchor=H8#H8\">",
"     \"Course and management of chronic aortic regurgitation in adults\", section on 'Chronic AR'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with mild to moderate AR have excellent survival rates and require no intervention. Surgery is indicated in patients with severe AR at the onset of symptoms or decreasing left ventricular function (ie, LVEF &le;50 percent),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    increasing left ventricular size (ie, LV end diastolic dimension &ge;75mm,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    LV end systolic dimension &ge;55 mm) assessed by echocardiography. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/29/25050?source=see_link&amp;anchor=H21#H21\">",
"     \"Course and management of chronic aortic regurgitation in adults\", section on 'Indications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The role of vasodilator therapy in patients with aortic regurgitation is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/14/14567?source=see_link\">",
"     \"Vasodilator therapy in severe chronic aortic regurgitation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10513009\">",
"    <span class=\"h3\">",
"     Management of aortic stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical management of asymptomatic aortic stenosis includes serial evaluation, treatment of associated cardiovascular disease, and limitation of physical activity, as appropriate. No medical therapies have been proven to delay progression of leaflet disease. Patients should receive education about the expected disease course and symptoms that should be reported, such as dyspnea, reduced exercise tolerance, exertional chest pain, lightheadedness, and syncope. Serial evaluation is recommended to monitor for development of symptoms and increasing severity of aortic stenosis by examination and echocardiography. These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2025?source=see_link&amp;anchor=H2#H2\">",
"     \"Medical management of asymptomatic aortic stenosis in adults\", section on 'Serial evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30551?source=see_link\">",
"     \"Natural history of aortic stenosis in adults\"",
"    </a>",
"    .)",
"    <strong>",
"    </strong>",
"   </p>",
"   <p>",
"    Symptomatic aortic stenosis is an indication for aortic valve replacement. Surgery in such patients is associated with marked reduction in symptoms and mortality. With certain exceptions, valve replacement should not be performed for isolated, severe AS in asymptomatic patients as discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=see_link\">",
"     \"Indications for valve replacement in aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Palliative care is recommended for severe symptomatic inoperable AS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/43/41654?source=see_link\">",
"     \"Medical management of symptomatic aortic stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10513017\">",
"    <span class=\"h3\">",
"     Management of mixed aortic valve disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combined aortic regurgitation and stenosis produces a variable clinical picture dependent on whether regurgitation or stenosis is the dominant lesion, or whether both lesions are equally significant. Therapy is dictated by close supervision (ie, 6 to 12 monthly visits) by clinical examination for development of symptoms and echocardiography for progression of valve disease and evidence of left ventricular dysfunction. Aortic valve replacement is indicated if symptoms develop",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    left ventricular function deteriorates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10513025\">",
"    <span class=\"h3\">",
"     Management of tricuspid valve disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although data are limited, severe tricuspid stenosis may be amenable to percutaneous balloon valvotomy. Surgical correction of the stenotic lesion is indicated in patients whose valve is not treatable with balloon techniques. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/27/5558?source=see_link\">",
"     \"Tricuspid stenosis: Clinical features, diagnosis, and percutaneous tricuspid balloon valvotomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management of tricuspid regurgitation, including indications for surgery, is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/48/30471?source=see_link&amp;anchor=H3#H3\">",
"     \"Management and prognosis of tricuspid regurgitation\", section on 'Management'",
"    </a>",
"    .) Tricuspid regurgitation often accompanies rheumatic mitral valve disease and often progresses after mitral valve surgery. For patients with tricuspid regurgitation and mitral regurgitation undergoing surgery for correction of mitral valve disease, concurrent tricuspid valve annuloplasty is indicated if tricuspid regurgitation is severe, as well as in other settings. The rationale and indications for concurrent tricuspid valvuloplasty at the time of mitral valve surgery are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25096?source=see_link\">",
"     \"Indications for corrective surgery in severe chronic primary mitral regurgitation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6449814\">",
"    <span class=\"h3\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy presents a unique set of problems for women with valve disease including those with prosthetic heart valves. These issues are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29097?source=see_link\">",
"     \"Acquired heart disease and pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1882?source=see_link\">",
"     \"Management of pregnant women with prosthetic heart valves\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512848\">",
"    <span class=\"h1\">",
"     HEALTH MAINTENANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, secondary prevention of rheumatic fever is recommended in patients with rheumatic heart disease. (See",
"    <a class=\"local\" href=\"#H7989029\">",
"     'Minimizing disease progression'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Annual influenza vaccination and meticulous dental hygiene with annual check-ups are recommended for patients with RHD. Prophylaxis against infective endocarditis (IE) is recommended for patients with prosthetic heart valves or a previous history of IE who undergo invasive dental procedures. Endocarditis prophylaxis guidelines are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10512840\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rheumatic heart disease (RHD) is the leading cause of heart disease in children and young adults under the age of 40 years who live in developing countries. (See",
"      <a class=\"local\" href=\"#H7988558\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute rheumatic fever causes a pancarditis, affecting the valve leaflets pericardium, epicardium, myocardium, and endocardium. Mitral regurgitation (with or without aortic regurgitation) is the most common valve lesions. (See",
"      <a class=\"local\" href=\"#H16376507\">",
"       'Acute rheumatic fever'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The incidence and pattern of mitral valve pathology in RHD varies according to age and geography [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/8\">",
"       8",
"      </a>",
"      ]. In general, younger patients under the age of 30 years present predominantly with isolated mitral regurgitation, whereas middle aged adult patients develop mitral stenosis from the third decade, with mixed mitral valve disease becoming more dominant in older patients. (See",
"      <a class=\"local\" href=\"#H24385710\">",
"       'Stages of disease and relationship to age'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Echocardiography screening is recommended for children and young adults from communities and countries where RHD is endemic. We recommend taking a history for prior acute rheumatic fever, performing echocardiography in all, and then clinical cardiac evaluation of cases with abnormal echocardiography. [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14617/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with mild carditis (eg, mild mitral regurgitation or healed carditis) should receive secondary prophylaxis for rheumatic fever for 10 years after the last attack, or at least until 25 years of age (whichever is longer). Patients with more severe valvular damage (eg, causing heart failure) or after valve surgery should receive lifelong secondary prophylaxis. (See",
"      <a class=\"local\" href=\"#H7989029\">",
"       'Minimizing disease progression'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     WHO Technical Report, Series. Rheumatic fever and rheumatic heart disease: Report of a WHO expert panel. Geneva 29 October - 1 November 2001. Geneva: WHO; 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/2\">",
"      Ntusi NB, Mayosi BM. Epidemiology of heart failure in sub-Saharan Africa. Expert Rev Cardiovasc Ther 2009; 7:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/3\">",
"      Bocchi EA, Guimar&atilde;es G, Tarasoutshi F, et al. Cardiomyopathy, adult valve disease and heart failure in South America. Heart 2009; 95:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/4\">",
"      Longo-Mbenza B, Bayekula M, Ngiyulu R, et al. Survey of rheumatic heart disease in school children of Kinshasa town. Int J Cardiol 1998; 63:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/5\">",
"      Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007; 357:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/6\">",
"      Paar JA, Berrios NM, Rose JD, et al. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol 2010; 105:1809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/7\">",
"      Anabwani GM, Bonhoeffer P. Prevalence of heart disease in school children in rural Kenya using colour-flow echocardiography. East Afr Med J 1996; 73:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/8\">",
"      Sliwa K, Carrington M, Mayosi BM, et al. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J 2010; 31:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/9\">",
"      Tibazarwa KB, Volmink JA, Mayosi BM. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 2008; 94:1534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/10\">",
"      Essop MR, Nkomo VT. Rheumatic and nonrheumatic valvular heart disease: epidemiology, management, and prevention in Africa. Circulation 2005; 112:3584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/11\">",
"      Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992; 268:2069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/12\">",
"      Ferrieri P, Jones Criteria Working Group. Proceedings of the Jones Criteria workshop. Circulation 2002; 106:2521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/13\">",
"      Marcus RH, Sareli P, Pocock WA, et al. Functional anatomy of severe mitral regurgitation in active rheumatic carditis. Am J Cardiol 1989; 63:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/14\">",
"      Minich LL, Tani LY, Pagotto LT, et al. Doppler echocardiography distinguishes between physiologic and pathologic \"silent\" mitral regurgitation in patients with rheumatic fever. Clin Cardiol 1997; 20:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/15\">",
"      Meira ZM, Goulart EM, Colosimo EA, Mota CC. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart 2005; 91:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/16\">",
"      BLAND EF, DUCKETT JONES T. Rheumatic fever and rheumatic heart disease; a twenty year report on 1000 patients followed since childhood. Circulation 1951; 4:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/17\">",
"      FEINSTEIN AR, WOOD HF, SPAGNUOLO M, et al. RHEUMATIC FEVER IN CHILDREN AND ADOLESCENTS. A LONG-TERM EPIDEMIOLOGIC STUDY OF SUBSEQUENT PROPHYLAXIS, STREPTOCOCCAL INFECTIONS, AND CLINICAL SEQUELAE. VII. CARDIAC CHANGES AND SEQUELAE. Ann Intern Med 1964; 60:SUPPL 5:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/18\">",
"      Vijayaraghavan G, Cherian G, Krishnaswami S, et al. Rheumatic aortic stenosis in young patients presenting with combined aortic and mitral stenosis. Br Heart J 1977; 39:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/19\">",
"      Strasser T, Dondog N, El Kholy A, et al. The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project. Bull World Health Organ 1981; 59:285.",
"     </a>",
"    </li>",
"    <li>",
"     Chesler, E. Rheumatic Valvular Disease. In: Clinical Cardiology, 5, Springer-Verlag, New York 1993. p.263.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/21\">",
"      Mayosi B, Robertson K, Volmink J, et al. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J 2006; 96:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/22\">",
"      Robertson KA, Volmink JA, Mayosi BM. Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa--the Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme. S Afr Med J 2006; 96:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/23\">",
"      Carapetis JR. Rheumatic heart disease in Asia. Circulation 2008; 118:2748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/24\">",
"      Manyemba J, Mayosi BM. Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever--a systematic review. S Afr Med J 2003; 93:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/25\">",
"      Marijon E, Ou P, Celermajer DS, et al. Echocardiographic screening for rheumatic heart disease. Bull World Health Organ 2008; 86:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/26\">",
"      Carapetis JR, Hardy M, Fakakovikaetau T, et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat Clin Pract Cardiovasc Med 2008; 5:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/27\">",
"      Marijon E, Celermajer DS, Tafflet M, et al. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation 2009; 120:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/28\">",
"      Oliveira JM, Antunes MJ. Mitral valve repair: better than replacement. Heart 2006; 92:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/29\">",
"      Chauvaud S, Fuzellier JF, Berrebi A, et al. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation 2001; 104:I12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/30\">",
"      Kumar AS, Talwar S, Saxena A, et al. Results of mitral valve repair in rheumatic mitral regurgitation. Interact Cardiovasc Thorac Surg 2006; 5:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/31\">",
"      Antunes MJ. Mitral valvuloplasty, a better alternative. Comparative study between valve reconstruction and replacement for rheumatic mitral valve disease. Eur J Cardiothorac Surg 1990; 4:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14617/abstract/32\">",
"      Kim JB, Kim HJ, Moon DH, et al. Long-term outcomes after surgery for rheumatic mitral valve disease: valve repair versus mechanical valve replacement. Eur J Cardiothorac Surg 2010; 37:1039.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13612 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-210.101.131.232-3CA5444EA1-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14617=[""].join("\n");
var outline_f14_17_14617=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10512840\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16376453\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7988558\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10512855\">",
"      NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16376507\">",
"      Acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10512862\">",
"      Transition from acute to chronic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23709418\">",
"      Chronic valve disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24385710\">",
"      - Stages of disease and relationship to age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10512869\">",
"      - Mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10512876\">",
"      - Mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10512883\">",
"      - Mixed mitral stenosis/regurgitation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10512890\">",
"      - Aortic regurgitation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10512897\">",
"      - Aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10512904\">",
"      - Tricuspid valve disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10512933\">",
"      SCREENING IN ENDEMIC SETTINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10512941\">",
"      Rationale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10512948\">",
"      Types of screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10512964\">",
"      Screening summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10512972\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7989029\">",
"      Minimizing disease progression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7989068\">",
"      Valve disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10512979\">",
"      - Management of mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10512986\">",
"      - Management of mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H6450255\">",
"      Atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H6450263\">",
"      Thromboembolism prevention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10512993\">",
"      - Management of mixed mitral disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10513001\">",
"      - Management of aortic regurgitation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10513009\">",
"      - Management of aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10513017\">",
"      - Management of mixed aortic valve disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10513025\">",
"      - Management of tricuspid valve disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6449814\">",
"      - Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10512848\">",
"      HEALTH MAINTENANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10512840\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/13612\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/13612|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/2/3117\" title=\"table 1\">",
"      Methods to assess cardiovascular disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/13/24795\" title=\"table 2\">",
"      Diagnostic criteria for rheumatic heart disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29097?source=related_link\">",
"      Acquired heart disease and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=related_link\">",
"      Clinical manifestations and diagnosis of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/29/25050?source=related_link\">",
"      Course and management of chronic aortic regurgitation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8327?source=related_link\">",
"      Epidemiology and pathogenesis of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/9/149?source=related_link\">",
"      Etiology, clinical features, and evaluation of tricuspid regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25096?source=related_link\">",
"      Indications for corrective surgery in severe chronic primary mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=related_link\">",
"      Indications for valve replacement in aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/48/30471?source=related_link\">",
"      Management and prognosis of tricuspid regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1882?source=related_link\">",
"      Management of pregnant women with prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/37/4697?source=related_link\">",
"      Medical management and indications for intervention in mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2025?source=related_link\">",
"      Medical management of asymptomatic aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/43/41654?source=related_link\">",
"      Medical management of symptomatic aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30551?source=related_link\">",
"      Natural history of aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/29/18901?source=related_link\">",
"      Natural history of mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=related_link\">",
"      Overview of atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33593?source=related_link\">",
"      Overview of the management of chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36901?source=related_link\">",
"      Pathophysiology and stages of chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/18/13610?source=related_link\">",
"      Pathophysiology, clinical features, and evaluation of mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44070?source=related_link\">",
"      Treatment and prevention of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/27/5558?source=related_link\">",
"      Tricuspid stenosis: Clinical features, diagnosis, and percutaneous tricuspid balloon valvotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/14/14567?source=related_link\">",
"      Vasodilator therapy in severe chronic aortic regurgitation in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_17_14618="Detailed neurologic assessment of infants and children";
var content_f14_17_14618=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Detailed neurologic assessment of infants and children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/17/14618/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/17/14618/contributors\">",
"     Suresh Kotagal, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/17/14618/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/17/14618/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/17/14618/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/17/14618/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/17/14618/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H10929372\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who present with or who are found to have neurologic or neuromuscular abnormalities on a general physical examination should undergo a complete neurologic assessment [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14618/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The elements of a complete neurological assessment are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Focused clinical history",
"     </li>",
"     <li>",
"      Detailed neurological examination",
"     </li>",
"     <li>",
"      Additional parts of the general physical examination that are relevant to child neurology",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In some cases, developmental screening tests are also helpful.",
"   </p>",
"   <p>",
"    These steps are detailed in this topic review. The neurologic assessment of neonates and adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14505?source=see_link\">",
"     \"Neurological examination of the newborn\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38377?source=see_link\">",
"     \"The detailed neurologic examination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10928921\">",
"    <span class=\"h1\">",
"     THE CASE HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The objectives of taking a clinical history are to establish rapport and trust with the child and family, to understand the nature of their health concerns regardless of whether or not they pertain to the nervous system, and to anatomically localize the neurological symptoms.",
"   </p>",
"   <p>",
"    In children seen in the outpatient setting, history taking is often facilitated by mailing a questionnaire to the family in advance of the visit that includes questions pertinent to current and past illnesses, family history, and growth and development. The family is advised to complete the questionnaire in advance and bring it to the doctor visit. A skilled clinician is often able to arrive at a diagnosis by the time a complete history has been taken, and uses the examination to confirm the diagnosis and determine the extent of impairment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10928936\">",
"    <span class=\"h2\">",
"     History of present illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should document the duration of symptoms, whether they are constant or episodic (as in a transient ischemic attack, syncope, seizure, or migraine), and whether they are static, progressive, or resolving. In addition, the history may suggest localization to a specific anatomical region. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Involvement of the cerebral cortex should be suspected in patients with cognitive dysfunction",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      seizures.",
"     </li>",
"     <li>",
"      Involvement of the brainstem may be accompanied by double vision, dizziness, dysphagia, hoarseness of voice, or impaired equilibrium.",
"     </li>",
"     <li>",
"      Cerebellar disorders may be associated with altered equilibrium and coordination in the trunk or extremities.",
"     </li>",
"     <li>",
"      Disorders of the spinal cord may result in dissociation of motor and sensory function below a certain altitudinal plane,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bowel and bladder dysfunction.",
"     </li>",
"     <li>",
"      Disorders of the motor unit (anterior horn cells, peripheral nerve, neuromuscular junction, muscle) should be suspected in patients with weakness manifested by inability to climb stairs, raise the arms, grasp, stand, or walk.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to ask questions about whether, and to what extent, the neurological disorder has impacted cognition, behavior, and language; the degree to which activities of daily living have been compromised; and what rehabilitative measures have been put in place. It is a common practice to inquire about activities a handicapped child cannot carry out. It is equally important to ask about activities the patient can do and enjoy because these skills can be targeted for further development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10928944\">",
"    <span class=\"h2\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should note any current medications (and alternative medicines or nutritional supplements), with the form of the medication (capsule, tablet, suspension), strength in",
"    <span class=\"nowrap\">",
"     milligrams/grams,",
"    </span>",
"    frequency, and route of administration. In addition, the medications that the child has taken in the past, as well as the response to these medications, should be noted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10928952\">",
"    <span class=\"h2\">",
"     Allergy history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergies to medications and the nature of the allergic reaction should be recorded. This information may inform the choice of therapies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10928960\">",
"    <span class=\"h2\">",
"     Family history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many childhood neurological disorders are inherited. Thus, the clinician should inquire about the number of siblings, their gender and health, the age and health of the parents, and the family history of neurologic and systemic disorders and of consanguinity. If other family members have neurologic disease, a pedigree chart is often helpful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10928968\">",
"    <span class=\"h2\">",
"     Pregnancy, perinatal, and neonatal history",
"    </span>",
"   </p>",
"   <p>",
"    The prenatal history should include the following elements:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mother's age at the time of pregnancy",
"     </li>",
"     <li>",
"      History of mother&rsquo;s previous pregnancies (gravida, para, miscarriages, and gestational age at the time of miscarriages)",
"     </li>",
"     <li>",
"      Prenatal exposure to prescription and illicit drugs, alcohol, radiation, and infections, and the fetus&rsquo; gestational age at the time of exposure",
"     </li>",
"     <li>",
"      Amount of maternal weight gain during the pregnancy (because excessive maternal weight gain may accompany preeclampsia and cause placental insufficiency; poor maternal weight gain may be associated with fetal growth restriction) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19304?source=see_link\">",
"       \"Weight gain and loss in pregnancy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Whether fetal movements were reduced (as seen in infantile spinal muscular atrophy) or exaggerated (as seen in intrauterine seizures associated with pyridoxine dependency)",
"     </li>",
"     <li>",
"      Results of prenatal head ultrasound studies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The labor and delivery history should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gestational age at the time of onset of labor, and whether labor was spontaneous or induced",
"     </li>",
"     <li>",
"      Fetal presentation, length of the labor, and whether vacuum or forceps extraction was used",
"     </li>",
"     <li>",
"      APGAR scores at 1, 5, and 10 minutes, respectively (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36105?source=see_link&amp;anchor=H3#H3\">",
"       \"Overview of the routine management of the healthy newborn infant\", section on 'Apgar score'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Whether the infant needed resuscitation",
"     </li>",
"     <li>",
"      The infant&rsquo;s weight, length, and head circumference at birth. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Significant events in the first week of life include the need for ventilatory support, oxygen administration, resuscitation, artificial hypothermia, exchange transfusion, status epilepticus, metabolic derangements, feeding difficulties, and coma. Impaired sucking or swallowing and sleep-wake difficulties in the first month of life are subtle markers of brain dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10928976\">",
"    <span class=\"h2\">",
"     Developmental history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should record the child&rsquo;s age at acquisition of developmental milestones, such as social smiling, developing adequate head control, gurgling, reaching out for objects, rolling over, being able to maintain a sitting position, coming to a sitting position independently, crawling, walking independently, babbling, and use of first words, phrases, and sentences (",
"    <a class=\"graphic graphic_table graphicRef70142 \" href=\"UTD.htm?18/62/19436\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14618/abstract/3\">",
"     3",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Some parents are unable to recall the exact age at which these milestones were achieved. They may, however, have a good recollection of events surrounding the child's first birthday; thus, one can help jog their memory by asking about the child's abilities at that time. The examiner should be aware that, in neurodegenerative disorders, a plateau in development may precede the start of developmental regression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10928984\">",
"    <span class=\"h2\">",
"     Review of other systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should inquire about underlying medical conditions, some of which may have neurologic symptoms. If any disorder is present, the clinician should document the symptoms, treatment, and status of these disorders (ie, resolving, static, or deteriorating).",
"   </p>",
"   <p>",
"    Many states or provinces conduct comprehensive newborn screens. An inquiry into the results of the newborn screen may be helpful. Although screening programs are designed for high sensitivity, false-negative results may occur, particularly in premature or medically complicated infants. Some forms of congenital hypothyroidism are not consistently captured by newborn screening, so testing should be repeated if there is a clinical suspicion for this disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/2/2088?source=see_link\">",
"     \"Newborn screening\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2682?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical features and detection of congenital hypothyroidism\", section on 'Newborn screening programs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infants and children with cerebral palsy often have a variety of problems attributable to their neurologic dysfunction, including dysphagia, gastroesophageal reflux, chronic constipation, respiratory difficulties, chronic aspiration into the tracheobronchial tree, sleep initiation and maintenance problems, impaired ambulation, scoliosis, deformities around joints of the extremities, and strabismus. In such children, the clinical history should document their current management, including whether they are using a feeding gastrostomy, spine instrumentation, intrathecal",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/44/7878?source=see_link\">",
"     baclofen",
"    </a>",
"    pump, vagus nerve stimulator, or orthotics. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29209?source=see_link\">",
"     \"Clinical features of cerebral palsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10928992\">",
"    <span class=\"h1\">",
"     NEUROLOGIC EXAMINATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10928999\">",
"    <span class=\"h2\">",
"     General concepts",
"    </span>",
"    &nbsp;&mdash;&nbsp;When examining toddlers, the initial phase of inspection is best conducted while the child is seated in the parent's lap. This minimizes apprehension, which tends to alter the assessment of higher cortical functions, muscle tone and tendon reflexes. It is also advisable to defer uncomfortable and anxiety-provoking procedures until the end of the session, such as funduscopy, otoscopy, and checking of the gag reflex.",
"   </p>",
"   <p>",
"    A collection of videos depicting elements of the neurological examination in infants and children can be viewed on the",
"    <a class=\"external\" href=\"file://library.med.utah.edu/pedineurologicexam/html/home_exam.html\">",
"     Pediatric NeuroLogic Exam website",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14618/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929007\">",
"    <span class=\"h2\">",
"     Higher cortical functions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observations of infants and toddlers during play (eg, while stacking blocks or playing with an age-appropriate toy) can provide valuable information about the patient's attention span, gross and fine motor coordination, and problem solving abilities. In addition, the following age-appropriate questions help to assess the higher cortical functions and yield clues to specific learning disabilities, attention deficit disorder, and mild mental retardation (",
"    <a class=\"graphic graphic_table graphicRef78835 \" href=\"UTD.htm?18/23/18812\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In infants of 6 to 12 months age, awareness of the surroundings, interaction with the examiner (social smile, inquisitiveness, and habituation), cooing and gurgling, and making of nonspecific &ldquo;mama&rdquo; and &ldquo;dada&rdquo; sounds should be assessed.",
"     </li>",
"     <li>",
"      By 12 to 20 months, the child should have developed a six to eight word vocabulary, should be able to comprehend simple one step commands, and point to two to three body parts.",
"     </li>",
"     <li>",
"      By 24 months, the patient should be able to name two to three body parts, and use phrases and simple sentences.",
"     </li>",
"     <li>",
"      The concept of self (referring to oneself as &ldquo;I&rdquo;, knowledge of one's own name and age) appears between 24 and 30 months.",
"     </li>",
"     <li>",
"      By 36 months, the child is able to count three objects, understand prepositional concepts (eg, under and over), ask questions, and name three colors.",
"     </li>",
"     <li>",
"      The ability to copy a square and a cross appears by 48 months, to copy a triangle by age six years, and a diamond by age seven years.",
"     </li>",
"     <li>",
"      A first grader (generally age five to six) can spell simple monosyllabic words and count to 10.",
"     </li>",
"     <li>",
"      By second grade, the child should be able to do simple addition and subtraction, and read polysyllabic words.",
"     </li>",
"     <li>",
"      Beyond the age of eight to nine years, the concepts of reading, spelling, calculation ability, general knowledge, geography, logic, and reasoning evolve exponentially.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929015\">",
"    <span class=\"h2\">",
"     Cranial nerves",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each cranial nerve (CN) is tested by performance of a specific motor or sensory test. Testing in infants is often by observation for specific movements and responses, and is less reliable. Multiple observation sessions may be helpful. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929022\">",
"    <span class=\"h3\">",
"     I (olfactory)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sense of smell, mediated by CN I, can be tested by ability to detect alcohol or peppermint. This sense may be impaired after closed head injury and in infants with arhinencephaly-holoprosencephaly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929029\">",
"    <span class=\"h3\">",
"     II (optic)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The function of CN II is assessed by the following tests of visual function:",
"   </p>",
"   <p>",
"    Testing visual acuity &ndash; In an infant, visual acuity can be tested by observing the infant reach for objects of varying size. Infant older than six months of age will usually reach for scraps of paper less than 5 mm in size when they are placed on a dark background. Standard tests can be used in older children who can recognize objects, letters, or numbers. The narrow, alternating black and white stripes painted onto a rotating drum should elicit optokinetic nystagmus, with quick jerks of the eyes in a direction opposite to the movement of the drum or tape. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24505?source=see_link&amp;anchor=H12#H12\">",
"     \"Visual development and vision assessment in infants and children\", section on 'Visual acuity tests'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Visual fields &ndash; Visual fields can be tested by introducing objects into the peripheral field of vision as the child focuses on an object held directly in front of him or her. The lateral and superior fields of vision can be assessed more easily than can the nasal fields. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11194?source=see_link&amp;anchor=H19#H19\">",
"     \"The pediatric physical examination: HEENT\", section on 'Vision'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pupillary light response (direct and consensual) &ndash; A normal pupillary light reflex requires CN II and III. An asymmetric, constricted pupil in association with ptosis, enophthalmos, and anhidrosis is seen with ipsilateral Horner's syndrome as a result of sympathetic denervation of the pupil. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32262?source=see_link\">",
"     \"Horner's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Funduscopy &ndash; Funduscopy of children requires patience, and is best accomplished in a dimly lit room with the patient gazing straight ahead. The parent or caretaker can be requested to keep a bright object in the hand, upon which the child is asked to focus. The ability of the clinician to obtain an adequate funduscopic examination is often compromised by lack of patient cooperation, nystagmus, or small pupils. In this case, consultation should be sought with an ophthalmologist.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The optic disc is normally pink in complexion (",
"      <a class=\"graphic graphic_picture graphicRef53796 \" href=\"UTD.htm?4/1/4112\">",
"       picture 1",
"      </a>",
"      ). Optic disc pallor may suggest atrophy (",
"      <a class=\"graphic graphic_picture graphicRef76278 \" href=\"UTD.htm?25/62/26592\">",
"       picture 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/47/6906?source=see_link&amp;anchor=H26#H26\">",
"       \"Congenital anomalies and acquired abnormalities of the optic nerve\", section on 'Atrophy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypoplasia of the optic disc (normal complexion, but small size) may accompany septo-optic dysplasia, which can be associated with hypothalamic insufficiency and hypopituitarism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/47/6906?source=see_link&amp;anchor=H5#H5\">",
"       \"Congenital anomalies and acquired abnormalities of the optic nerve\", section on 'Hypoplasia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Blurring of the optic disc margins along with loss of the optic disc cup and venous pulsations is seen in papilledema (",
"      <a class=\"graphic graphic_picture graphicRef50378 \" href=\"UTD.htm?30/30/31215\">",
"       picture 3",
"      </a>",
"      ). About 30 percent of subjects lack venous pulsations even in the absence papilledema. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/47/6906?source=see_link&amp;anchor=H21#H21\">",
"       \"Congenital anomalies and acquired abnormalities of the optic nerve\", section on 'Papilledema'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A &ldquo;cherry red&rdquo; macular spot (",
"      <a class=\"graphic graphic_picture graphicRef65650 \" href=\"UTD.htm?19/14/19680\">",
"       picture 4",
"      </a>",
"      ) is seen in lysosomal storage disorders, such as Tay Sachs disease and Niemann Pick disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/24/12681?source=see_link&amp;anchor=H43#H43\">",
"       \"Prenatal screening for genetic disease in the Ashkenazi Jewish population\", section on 'Tay-Sachs disease'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20489?source=see_link\">",
"       \"Overview of Niemann-Pick disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chorioretinitis, which sometimes appears like &ldquo;pepper sprinkled on a red table cloth&rdquo;, can accompany congenital cytomegalovirus infections. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=see_link\">",
"       \"Cytomegalovirus infection and disease in newborns, infants, children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Flame shaped retinal hemorrhages (",
"      <a class=\"graphic graphic_picture graphicRef69754 \" href=\"UTD.htm?38/62/39919\">",
"       picture 5",
"      </a>",
"      ) may accompany the shaken infant syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=see_link&amp;anchor=H6#H6\">",
"       \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\", section on 'Retinal hemorrhages'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929043\">",
"    <span class=\"h3\">",
"     III (oculomotor), IV (trochlear), and VI (abducens)",
"    </span>",
"    &nbsp;&mdash;&nbsp;CN III, IV, and VI are required for extraocular movements in the horizontal, vertical, and oblique planes, and can be tested by assessing the child&rsquo;s ability to track a brightly colored toy or soft light. The corneal light reflex is also a helpful test to determine eye alignment (strabismus or esotropia). When a light source is held directly in front of a patient who is staring straight ahead, normal eye alignment will reveal a symmetric reflex in the center of each pupil (",
"    <a class=\"graphic graphic_figure graphicRef63631 \" href=\"UTD.htm?28/23/29040\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Paralysis of extraocular muscles leads to eye deviation at rest [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14618/abstract/2\">",
"     2",
"    </a>",
"    ] in the following patterns:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Deviation down and out: paralysis of the inferior oblique muscle (CN III) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/34/40487?source=see_link\">",
"       \"Third cranial nerve (oculomotor nerve) palsy in children\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Deviation laterally: paralysis of the medial rectus (CN III)",
"     </li>",
"     <li>",
"      Deviation upwards: paralysis of the inferior rectus (CN III)",
"     </li>",
"     <li>",
"      Deviation down and inwards: paralysis of the superior rectus (CN III)",
"     </li>",
"     <li>",
"      Deviation upwards and out: paralysis of the superior oblique (CN IV) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/44/12999?source=see_link\">",
"       \"Fourth cranial nerve (trochlear nerve) palsy in children\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Deviation inwards: paralysis of the lateral rectus (CN VI) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43046?source=see_link&amp;anchor=H3#H3\">",
"       \"Sixth cranial nerve (abducens nerve) palsy in children\", section on 'Clinical manifestations'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ptosis (drooping of the upper eyelid and encroachment on the pupillary aperture) may accompany sympathetic paralysis from lesions of the cranial nerve III, Horner syndrome, myopathies, myasthenia gravis, and eye structural lesions (eg, neurofibroma). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/33/31255?source=see_link\">",
"     \"Overview of ptosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929058\">",
"    <span class=\"h3\">",
"     V (trigeminal)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sensory function of CN V can be tested by the response to light touch over the face (use a tissue) and by sensation on the cornea and conjunctiva. (See",
"    <a class=\"local\" href=\"#H10929173\">",
"     'Superficial reflexes'",
"    </a>",
"    below.) Motor function of CN V is tested by assessing masseter muscle strength (asking the child to open the jaw against resistance).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929065\">",
"    <span class=\"h3\">",
"     VII (facial)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The function of CN VII can be assessed by observing for symmetry of the nasolabial folds, assessing eye lid muscle strength, and the ability to wrinkle the forehead symmetrically. In addition, CN VII mediates taste sensation over the anterior two thirds of the tongue, and can be tested by applying two or three drops of a concentrated salt solution to the lateral edge of each half of the tongue using a cotton applicator, while the tongue is kept protruded.",
"   </p>",
"   <p>",
"    With nuclear and infranuclear lesions of CN VII, both the upper and lower halves of the face are paralyzed, whereas with supranuclear lesions, only the lower half of the face is affected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25257?source=see_link\">",
"     \"Facial nerve palsy in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21350096\">",
"    <span class=\"h3\">",
"     VIII (vestibulocochlear)",
"    </span>",
"    &nbsp;&mdash;&nbsp;In infants, hearing is tested by making a soft sound close to one ear, such as from rustling of paper. The infant should show an alerting response. By the age of five to six months, the infant may also be able to localize the sound to a specific quadrant. The procedure is then repeated for the opposite ear. In cooperative school age children, speech discrimination can be tested by softly whispering a number about one foot from the ear. The traditional Rinne and Weber tests can be used as well in older children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=see_link&amp;anchor=H7#H7\">",
"     \"Evaluation of hearing impairment in children\", section on 'Office hearing tests'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Poor head control, truncal unsteadiness, gait ataxia, nausea, vomiting and horizontal nystagmus may indicate vestibular system dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929080\">",
"    <span class=\"h3\">",
"     IX (glossopharyngeal) and X (vagus)",
"    </span>",
"    &nbsp;&mdash;&nbsp;CN IX and CN X are responsible for swallowing function, movement of the soft palate, and are often tested by eliciting a gag reflex. Salivary drooling or pooling of saliva also suggests dysfunction. Hoarseness of the voice can be caused by CN X dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929095\">",
"    <span class=\"h3\">",
"     XI (spinal accessory)",
"    </span>",
"    &nbsp;&mdash;&nbsp;CN XI mediates motor function in the trapezius or sternomastoids; its function is usually assessed by elevation of the shoulders and turning of the neck against resistance. The pattern of weakness caused by CN IX dysfunction depends on whether the lesion is peripheral or central. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38377?source=see_link&amp;anchor=H31#H31\">",
"     \"The detailed neurologic examination in adults\", section on 'Head rotation/shoulder elevation (CN XI)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929110\">",
"    <span class=\"h3\">",
"     XII (hypoglossal)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Function of CN XII in a child or adolescent is tested by asking the patient to stick out their tongue; normally the tongue should remain in the midline. In patients with peripheral lesions of CN XII, the tongue points towards the paretic side. CN XII dysfunction can also cause fasciculations (slow ripple like movements) in the tongue, and oromotor apraxia. Fasciculations are best observed with the mouth open and with the tongue kept immobile within the mouth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929125\">",
"    <span class=\"h2\">",
"     Motor system",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10930508\">",
"    <span class=\"h3\">",
"     Posture and movements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities are suggested by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Asymmetry at rest in infants.",
"     </li>",
"     <li>",
"      Opisthotonus (a brainstem release phenomenon due to bilateral cerebral cortical dysfunction). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14505?source=see_link&amp;anchor=H20#H20\">",
"       \"Neurological examination of the newborn\", section on 'Hypertonia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Abducted hips or &ldquo;frog-legged&rdquo; posture that accompanies hypotonia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14505?source=see_link&amp;anchor=H19#H19\">",
"       \"Neurological examination of the newborn\", section on 'Hypotonia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Fisting of the hand or holding the thumb adducted across the palm during quiet wakefulness (suggests corticospinal tract involvement). Closure of the hand during sleep is normal. &nbsp;",
"     </li>",
"     <li>",
"      Tremor (rhythmic, fine amplitude flexion-extension movements of the distal extremity).",
"     </li>",
"     <li>",
"      Myoclonus (quick, non-stereotyped jerks around a segment of the body). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18058?source=see_link&amp;anchor=H31#H31\">",
"       \"Hyperkinetic movement disorders in children\", section on 'Myoclonus'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Athetosis (slow, sinuous movement of the distal extremity with pronation of the distal extremity, generally due to a contralateral putaminal lesion). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18058?source=see_link&amp;anchor=H17#H17\">",
"       \"Hyperkinetic movement disorders in children\", section on 'Chorea, athetosis, and ballismus'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chorea (rapid, quasi-purposive, non-stereotyped movements of a segment of the body that is generally proximal). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18058?source=see_link&amp;anchor=H17#H17\">",
"       \"Hyperkinetic movement disorders in children\", section on 'Chorea, athetosis, and ballismus'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tics (highly stereotyped and repetitive movements). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29175?source=see_link&amp;anchor=H8#H8\">",
"       \"Nonepileptic paroxysmal disorders in children\", section on 'Tics and stereotypies'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Muscle atrophy, pseudohypertrophy (bulky appearance but with weakness), and fasciculations (ripple like movements of the muscles that accompany degeneration of anterior horn cells). Muscle atrophy implies decreased muscle bulk. It may be segmental or generalized, and may be due to a neuropathy, myopathy, or disuse. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/54/24425?source=see_link&amp;anchor=H44#H44\">",
"       \"Etiology and evaluation of the child with muscle weakness\", section on 'Muscle examination'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10930515\">",
"    <span class=\"h3\">",
"     Tone and strength",
"    </span>",
"    &nbsp;&mdash;&nbsp;Muscle tone is the resistance felt upon passive movement of a part of the body. In the extremities, it is assessed by placing a joint through its",
"    <strong>",
"     full range",
"    </strong>",
"    of movement. Hypotonia is characterized by decreased resistance to passive movement and hyperextension at the joints. Increased tone that is spastic in nature (abnormal lengthening-shortening reaction to stretch that has the feel of a &ldquo;clasp knife&rdquo;) tends to accompany pyramidal tract lesions. Increased tone that is",
"    <strong>",
"    </strong>",
"    characterized by muscle rigidity (has a &ldquo;lead pipe&rdquo; or &ldquo;cog-wheel&rdquo; feel during the range of motion) suggests extrapyramidal lesions. &nbsp;",
"   </p>",
"   <p>",
"    Weakness is elicited by asking the patient to move a part of the body against resistance (gravity, or gravity plus resistance imposed by the examiner). The Medical Research Council of Great Britain suggests grading weakness according to the following scale:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Grade",
"      <span class=\"nowrap\">",
"       0/5:",
"      </span>",
"      No muscle movement at all",
"     </li>",
"     <li>",
"      Grade",
"      <span class=\"nowrap\">",
"       1/5:",
"      </span>",
"      Presence of a flicker of movement",
"     </li>",
"     <li>",
"      Grade",
"      <span class=\"nowrap\">",
"       2/5:",
"      </span>",
"      Movement with gravity eliminated (eg, across the bed sheet)",
"     </li>",
"     <li>",
"      Grade",
"      <span class=\"nowrap\">",
"       3/5:",
"      </span>",
"      Movement against gravity",
"     </li>",
"     <li>",
"      Grade",
"      <span class=\"nowrap\">",
"       4/5:",
"      </span>",
"      Movement against gravity and some externally applied resistance",
"     </li>",
"     <li>",
"      Grade",
"      <span class=\"nowrap\">",
"       5/5:",
"      </span>",
"      Movement against gravity and good external resistance (normal)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Distal weakness (symmetric or asymmetric) generally accompanies peripheral neuropathy, while proximal muscle weakness (generally symmetric) is seen in myopathies. Patients with proximal (hip extensor) muscle weakness may exhibit a Gower's sign: when asked to come to a standing position from sitting on the floor, the patient will initially prop the hands against the floor or the lower extremities for support.",
"   </p>",
"   <p>",
"    Assessment for the pronator drift is a useful method of detecting upper motor neuron weakness [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14618/abstract/5\">",
"     5",
"    </a>",
"    ]. Initially, the child is asked to extend the upper extremities with palms down. The child is then asked to close the eyes, and rotate the extended arms so that the palms are facing upwards. During this turning maneuver with the eyes closed, a patient with upper motor neuron weakness may pull the elbow down and in.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10930531\">",
"    <span class=\"h3\">",
"     Coordination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with cerebellar dysfunction have difficulty in regulating the rate and range of muscle contraction (known as dysmetria), which may manifest as nystagmus, intention tremor, scanning speech, truncal or gait ataxia, or rebound phenomenon. To test for rebound phenomenon, the patient flexes the arm against resistance offered by the examiner, then the examiner abruptly releases the resistance. In rebound phenomenon, the patient is unable to stop the muscle contraction.",
"   </p>",
"   <p>",
"    Dysmetria can be assessed with finger to nose test: when seated with the elbows fully extended and the arms in a horizontal plane, the patient is asked to touch the index finger to his nose and then return to the starting position. Cerebellar deficits will impair performance on this test.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929133\">",
"    <span class=\"h2\">",
"     Sensory system",
"    </span>",
"    &nbsp;&mdash;&nbsp;A sensory examination in young children is often imprecise, and only gross deficits can be detected. Information obtained from sensory testing in a child below five to six years of age can be unreliable, and may need confirmation during a second examination session.",
"   </p>",
"   <p>",
"    In children older than five to six years, sensory function is evaluated in the same manner as in an adult. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38377?source=see_link&amp;anchor=H72#H72\">",
"     \"The detailed neurologic examination in adults\", section on 'Sensory examination'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vibration sense testing is performed with a 128 or 256 Hz tuning fork. After a vibrating tuning fork has been applied against a bony prominence in the upper or lower extremity, the vibration should be intermittently stopped to check whether the child is responding to the actual vibration, or just to the contact of the tuning fork against the skin. Impairment of vibration sense may suggest a large fiber peripheral neuropathy or dorsal spinal column dysfunction.",
"     </li>",
"     <li>",
"      Joint sense is checked by asking the patient to indicate (first with eyes open, then with eyes closed) whether the great toe or the thumb have been passively moved by the examiner upwards or downwards. Joint sense can also be tested with the Romberg test: The patient is asked to stand upright, keeping both feet together and close the eyes, with the examiner ready to catch the patient in case of a fall. Patients with preserved dorsal column function will continue to maintain stable balance with eyes closed, while those with dorsal column dysfunction will tend to stagger and fall (positive Romberg sign).",
"     </li>",
"     <li>",
"      Light touch is tested by checking response to tickling or to perception of the application of a cotton wisp on to the skin. Pin prick, and cool and warm stimuli are used for checking of the small diameter peripheral nerve fibers and of the spinothalamic tracts. Since pin prick testing and temperature testing give somewhat similar information about spinothalamic tract function, the pin prick may be omitted in younger children if temperature sensation is normal. Some common sensory landmarks include the plane of nipple (T4 segment), umbilicus (T10 segment) and perianal region (S4-5). A useful reference for motor and sensory has been published by the Medical Research Council of Great Britain [",
"      <a class=\"abstract\" href=\"UTD.htm?14/17/14618/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Testing of cortical sensory function consists of two point discrimination, stereognosis (detecting the shape of an object by touch) and graphesthesia (recognizing writing on the skin). Tactile stimuli are provided on to the volar aspect of the fingers for two point discrimination and over the palm of the hand for stereognosis and graphesthesia. The results may be asymmetric between the left and right sides in patients with cerebral cortical lesions, such as porencephaly or infarcts. For accurate interpretation of tests of cortical sensation, the primary, peripheral sensation needs to be preserved.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929141\">",
"    <span class=\"h2\">",
"     Tendon reflexes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The jaw, biceps, triceps, brachio-radialis, patellar, and ankle are commonly tested tendon reflexes, and all of these can usually be tested in infants and children. The joint under consideration should be at about 90 degrees and fully relaxed. In patients with cerebral palsy, exhortations to &ldquo;relax&rdquo; may paradoxically increase contraction of the muscles, and should thus be avoided. Instead, the patient should be put at ease during reflex testing with conversation.",
"   </p>",
"   <p>",
"    To elicit the reflex, let the head of the reflex drop onto the tendon at the following locations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Jaw &ndash; with the mouth held partially open and examiner&rsquo;s finger placed over the chin, the finger is lightly tapped with a reflex hammer to displace the mandible downwards. This elicits contraction of the mandible and slight closure of the mouth.",
"     </li>",
"     <li>",
"      Biceps &ndash; just anterior to the elbow",
"     </li>",
"     <li>",
"      Triceps &ndash; just posterior to the elbow",
"     </li>",
"     <li>",
"      Brachioradialis &ndash; just above the wrist, on the radial aspect of the forearm",
"     </li>",
"     <li>",
"      Knee (patellar) &ndash; just below the patella",
"     </li>",
"     <li>",
"      Ankle (Achilles) &ndash; just behind the ankle",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The elicitation of tendon reflexes provides information about multiple aspects of the nervous system. Findings can be interpreted as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Absent or diminished tendon reflexes &ndash; this generally indicates interruption of the muscle stretch reflex arc at the level. Since the afferent impulses generated after tapping a tendon with reflex hammer are carried via large diameter fibers, the absence of a tendon reflex could also signify involvement of large diameter sensory fibers in a peripheral nerve.",
"     </li>",
"     <li>",
"      Exaggerated tendon reflexes &ndash; this generally indicates disinhibition of the motor units owing to a pyramidal tract lesion. When the patellar reflex is elicited, spread to the opposite side in the form of a crossed adductor response (contraction of the contralateral hip muscle), or contraction of the plantar flexures of the foot are considered exaggerated and abnormal. Similarly, clonus (rhythmic muscle contractions elicited by the stimulus) is exaggerated and abnormal.",
"     </li>",
"     <li>",
"      Asymmetric tendon reflexes &ndash; this may indicate a cerebral hemispheric lesion. Asymmetry is most easily detected with a gentle stimulus.",
"     </li>",
"     <li>",
"      Differences between tendon reflexes in the upper and lower body &ndash; this may suggest a spinal cord lesion. As an example, the jaw jerk is the only tendon reflex that is mediated above the plane of the foramen magnum; thus, if the jaw jerk is of normal amplitude but the biceps and other tendon reflexes are exaggerated, this might be a clue to a cranio-vertebral junction lesion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929149\">",
"    <span class=\"h2\">",
"     Developmental reflexes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Developmental reflexes (also known as primitive reflexes) appear at a certain time during the course of brain development, and normally disappear with progressive maturation of cortical inhibitory functions. They are mediated at subcortical levels. Assessment of developmental reflexes is important in the newborn period and during infancy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14618/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Developmental reflexes are abnormal if:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      They are absent at an age when they should normally be present",
"     </li>",
"     <li>",
"      They are asymmetric, suggesting unilateral weakness",
"     </li>",
"     <li>",
"      They persist beyond a time they should have normally resolved, as this suggests impaired maturation of descending cortical inhibitory projections.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Common developmental reflexes, their descriptions, and time of appearance and resolution are listed in the following table (",
"    <a class=\"graphic graphic_table graphicRef58453 \" href=\"UTD.htm?26/3/26684\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14505?source=see_link&amp;anchor=H35#H35\">",
"     \"Neurological examination of the newborn\", section on 'Developmental'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929173\">",
"    <span class=\"h2\">",
"     Superficial reflexes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Superficial reflexes can be elicited by light stimulation of the plantar, conjunctival, abdominal, and cremaster areas.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The plantar reflex (S1) is elicited by stroking the plantar surface of the foot using a pointed but not sharp object (eg, the metal end of a reflex hammer). The stroke is from a lateral to medial direction, posterior to anterior, stopping short at the base of the great toes. The normal response is one flexion of all toes. Patients with corticospinal tract lesions manifest an extensor plantar response (Babinski sign), which is characterized by extension of the great toe and fanning of other toes.",
"     </li>",
"     <li>",
"      For the conjunctival reflex, gently touching a wisp of cotton or tissue to the surface of the conjunctiva will elicit an eye blink. The afferent loop of the reflex is via cranial nerve V, while the efferent loop is through the facial (VII) nerve. (See",
"      <a class=\"local\" href=\"#H10929043\">",
"       'III (oculomotor), IV (trochlear), and VI (abducens)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The superficial abdominal reflexes are elicited in the right and left upper abdominal quadrants (T8, 9) and also in the left and right lower abdominal quadrants (T11, 12). Stroking of a blunt metal object (eg, the metal end of a reflex hammer) in these quadrants in a medial to lateral direction elicits contraction of the abdominal muscles. Abdominal reflexes may be lost in case of a pyramidal tract lesion.",
"     </li>",
"     <li>",
"      The cremasteric reflex (L1-2) is elicited by stroking the medial aspect of the upper thigh, which elicits contraction of the cremaster muscle and elevation of the testis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929181\">",
"    <span class=\"h2\">",
"     Gait",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gait is best assessed by observing the patient walk barefooted down a long corridor with the legs and feet exposed.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Circumduction of a lower extremity may indicate spasticity, and is commonly observed in hemiparesis",
"     </li>",
"     <li>",
"      A broad-based, ataxic gait may accompany a cerebellar disorder",
"     </li>",
"     <li>",
"      A high steppage gait suggests peripheral neuropathy",
"     </li>",
"     <li>",
"      Patients with dystonia frequently show normal posture of the feet at rest but turn their feet inwards and walk on the outer edges of the feet",
"     </li>",
"     <li>",
"      Myopathies, such as Duchenne muscular dystrophy, may be associated with a waddling gait",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929189\">",
"    <span class=\"h2\">",
"     Spine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spine should be examined along its entire length for findings that might suggest an underlying congenital spinal cord anomaly, such as tethered cord syndrome or spina bifida occulta (eg, a midline tuft of hair, dermal sinus tract, or lipoma). Gross lesions (eg, meningocele and myelomeningocele) will of course be readily visualized. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=see_link\">",
"     \"Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with muscular dystrophy may display lumbar lordosis. Kyphoscoliosis may accompany degenerative disorders, such as Friedreich's ataxia and muscular dystrophies. Localized point tenderness over the spine may suggest underlying intervertebral disc herniation, inflammation, fracture, or neoplastic process. The range of motion of the spine should be evaluated at all levels when indicated. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929197\">",
"    <span class=\"h2\">",
"     Head",
"    </span>",
"    &nbsp;&mdash;&nbsp;The growth in size of the head is an indirect marker for increase in size of the brain, which measures approximately 450 g at birth and 1200 g by three to four years of age.",
"   </p>",
"   <p>",
"    The occipitofrontal head circumference (OFC) is measured using a paper or cloth tape that is placed across from just above the bridge of the nose to the external occipital protuberance. The head circumference is compared with the standard measurements for a given age. Serial head circumference measurements are more reliable than a single recording. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36665?source=see_link&amp;anchor=H3#H3\">",
"     \"Etiology and evaluation of microcephaly in infants and children\", section on 'Measurement'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Macrocephaly is defined as OFC greater than the 97th percentile for age. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3946?source=see_link&amp;anchor=H6#H6\">",
"       \"Etiology and evaluation of macrocephaly in infants and children\", section on 'Etiology'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      Microcephaly is usually defined as OFC less than the 2",
"      <sup>",
"       nd",
"      </sup>",
"      or 3",
"      <sup>",
"       rd",
"      </sup>",
"      percentile for age, although some individuals with OFC in this range have no clinical abnormality. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36665?source=see_link&amp;anchor=H6#H6\">",
"       \"Etiology and evaluation of microcephaly in infants and children\", section on 'Microcephaly'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The anterior fontanel is felt for bulging (raised intracranial pressure) or depression (dehydration). For consistency, serial evaluations of the fontanel should always be performed in the same position (eg, while supporting the infant who is not crying in the semi-upright position).",
"   </p>",
"   <p>",
"    The sagittal and coronal sutures are palpated for ridging (craniosynostosis) or separation (raised intracranial pressure). Patients with raised intracranial pressure may show frontal bossing, palpable separation of sutures, tense or bulging anterior fontanel, and prominent veins over the scalp. Premature closure of the sagittal suture may confer an elongated appearance of the skull in the antero-posterior plane with side to side flattening (dolichocephaly). Premature closure of the coronal suture may lead to brachycephaly, with shortening of the skull in the antero-posterior plane. Plagiocephaly or asymmetric flattening of the skull occurs when there is premature closure of one of the lambdoidal sutures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/37/10841?source=see_link\">",
"     \"Overview of craniosynostosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In young infants with enlarged heads, transillumination can be performed to detect fluid-filled intracranial lesions. This is generally possible up to about six months of age. Transillumination is carried out by placing a bright source of light against the scalp in a darkened room. Hydrocephalus, hydranencephaly, porencephalic cyst, and chronic subdural hematoma can be associated an increased transillumination. Auscultation of the head during infancy may reveal a bruit in patients with vein of Galen arterio-venous malformation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/54/5994?source=see_link&amp;anchor=H18#H18\">",
"     \"Hydrocephalus\", section on 'CNS malformations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929205\">",
"    <span class=\"h1\">",
"     ELEMENTS OF THE GENERAL PHYSICAL EXAMINATION RELEVANT TO CHILD NEUROLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clues to the diagnosis of many childhood neurological disorders can be obtained during a careful general physical examination. Additional detail on these disorders is available through the topic reviews linked below,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    in the open access databases",
"    <a class=\"external\" href=\"file://www.ncbi.nlm.nih.gov/omim\">",
"     Online Mendelian Inheritance in Man",
"    </a>",
"    (OMIM) or the National Center for Biotechnology information (NCBI)",
"    <a class=\"external\" href=\"file://www.ncbi.nlm.nih.gov/sites/GeneTests/review?db=genetests\">",
"     GeneReviews",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929213\">",
"    <span class=\"h2\">",
"     Dysmorphic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of an isolated unusual morphologic feature is common (noted in about 15 percent of newborns in one series), and is not generally associated with underlying abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14618/abstract/9\">",
"     9",
"    </a>",
"    ]. However, the presence of two or more unusual morphologic features is much less common (0.8 percent of newborns) and is associated with an increased likelihood of having a clinically important underlying anomaly.",
"   </p>",
"   <p>",
"    The following list of dysmorphic features is by no means complete, and the reader is referred to more comprehensive reviews on dysmorphology [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14618/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Hypotelorism",
"      </strong>",
"      may accompany the holoprosencephaly sequence and trisomy 13. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44581?source=see_link\">",
"       \"Facial clefts and holoprosencephaly\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/0/23562?source=see_link&amp;anchor=H14#H14\">",
"       \"Congenital cytogenetic abnormalities\", section on 'Trisomy 13 syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Hypertelorism",
"      </strong>",
"      is commonly observed in patients with cleft palate, Sotos syndrome (cerebral gigantism) and Apert, Saethre-Chotzen, Coffin-Lowry, and Aarskog syndromes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44581?source=see_link\">",
"       \"Facial clefts and holoprosencephaly\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10073?source=see_link&amp;anchor=H8#H8\">",
"       \"The child with tall stature or abnormally rapid growth\", section on 'Cerebral gigantism'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/18/8487?source=see_link&amp;anchor=H2#H2\">",
"       \"Craniosynostosis syndromes\", section on 'Apert syndrome'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/18/8487?source=see_link&amp;anchor=H12#H12\">",
"       \"Craniosynostosis syndromes\", section on 'Saethre-Chotzen syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Inner epicanthal folds",
"      </strong>",
"      accompany Down syndrome, Rubinstein Taybi syndrome, Smith Lemli Opitz syndrome, and Zellweger syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=see_link\">",
"       \"Clinical features and diagnosis of Down syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/44/11978?source=see_link&amp;anchor=H2157284#H2157284\">",
"       \"Microdeletion syndromes (chromosomes 12 to 22)\", section on '16p13.3 deletion syndrome (Rubinstein-Taybi syndrome)'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/52/23369?source=see_link&amp;anchor=H13#H13\">",
"       \"Causes and clinical manifestations of primary adrenal insufficiency in children\", section on 'Defects in cholesterol biochemistry'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8570?source=see_link&amp;anchor=H17#H17\">",
"       \"Peroxisomal disorders\", section on 'Zellweger syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Slanted palpebral fissures",
"      </strong>",
"      are common in Down syndrome, Apert syndrome, DiGeorge sequence, Miller Dieker syndrome, rhizomelic chondrodysplasia punctata, and Aarskog syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link\">",
"       \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/44/11978?source=see_link&amp;anchor=H2157776#H2157776\">",
"       \"Microdeletion syndromes (chromosomes 12 to 22)\", section on '17p13.3 deletion including PAFAH1B1 (Miller-Dieker syndrome)'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8570?source=see_link&amp;anchor=H34#H34\">",
"       \"Peroxisomal disorders\", section on 'Rhizomelic chondrodysplasia punctata type 1'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Prominent, full lips",
"      </strong>",
"      are common in Williams syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/14/34025?source=see_link&amp;anchor=H12329278#H12329278\">",
"       \"Microdeletion syndromes (chromosomes 1 to 11)\", section on '7q11.23 deletion syndrome (Williams syndrome)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Low set ears",
"      </strong>",
"      are seen in Noonan, Treacher Collins, Miller Dieker, Rubinstein Taybi, Smith Lemli Opitz, and Pena Shokier syndromes, as well as Trisomy 9 and 18. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10537?source=see_link&amp;anchor=H19#H19\">",
"       \"Causes of short stature\", section on 'Noonan syndrome'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/15/250?source=see_link&amp;anchor=H5#H5\">",
"       \"Syndromes with craniofacial abnormalities\", section on 'Treacher Collins syndrome'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/0/23562?source=see_link\">",
"       \"Congenital cytogenetic abnormalities\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       A single midline incisor",
"      </strong>",
"      in the maxilla may be associated with holoprosencephaly. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44581?source=see_link\">",
"       \"Facial clefts and holoprosencephaly\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929221\">",
"    <span class=\"h2\">",
"     Skin examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin findings associated with neurologic disease include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Tuberous sclerosis",
"      </strong>",
"      may be associated with hypopigmented patches, angiofibromas over the cheek (adenoma sebaceum), shagreen patches over the lumbar region (raised skin lesions with an irregular surface), and a brown fibrous plaque on the forehead. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=see_link&amp;anchor=H11#H11\">",
"       \"Tuberous sclerosis complex: Genetics, clinical features, and diagnosis\", section on 'Dermatologic features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Neurofibromatosis type I",
"      </strong>",
"      is associated with six or more caf&eacute;-au-lait spots (&gt;5 mm in a prepubertal child and &gt;15 mm in a postpubertal child), neurofibromas (soft, sessile nodules), and axillary or inguinal freckles. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=see_link&amp;anchor=H5#H5\">",
"       \"Neurofibromatosis type 1 (von Recklinghausen's disease)\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       A port-wine stain",
"      </strong>",
"      over one half of the face is characteristic of Sturge Weber syndrome. The lesion invariably involves the ophthalmic region of distribution of the trigeminal nerve. Many patients have an associated intracranial (leptomeningeal) angioma, with hemiplegia and focal epilepsy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4727?source=see_link\">",
"       \"Sturge-Weber syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Petechial hemorrhages",
"      </strong>",
"      , which confer a &ldquo;blueberry muffin&rdquo; appearance to the skin, may be seen in neonates with congenital cytomegalovirus infections. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=see_link&amp;anchor=H9#H9\">",
"       \"Cytomegalovirus infection and disease in newborns, infants, children and adolescents\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       A macular rash",
"      </strong>",
"      (located over the malar region of the face) is characteristic of systemic lupus erythematosus, whereas drug hypersensitivity reactions tend to have a rash with a generalized distribution. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10810?source=see_link\">",
"       \"Systemic lupus erythematosus in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Erythema migrans",
"      </strong>",
"      is a reddish target-shaped lesion that is characteristic of Lyme disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7225?source=see_link&amp;anchor=H4#H4\">",
"       \"Lyme disease: Clinical manifestations in children\", section on 'Erythema migrans'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Vitiligo",
"      </strong>",
"      may be associated with autoimmune disturbances such as myasthenia gravis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21193?source=see_link&amp;anchor=H6#H6\">",
"       \"Vitiligo\", section on 'Association with autoimmune disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Lax or redundant skin",
"      </strong>",
"      may accompany Coffin Lowry syndrome, Costello syndrome, and the Ehlers Danlos syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16377?source=see_link&amp;anchor=H4#H4\">",
"       \"Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Epidemiology, pathology, and molecular pathogenesis\", section on 'Inherited syndromes'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/56/2953?source=see_link&amp;anchor=H20#H20\">",
"       \"Clinical manifestations and treatment of the hypermobility syndrome\", section on 'Ehlers-Danlos syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Angiokeratomas",
"      </strong>",
"      , which are collections of small reddish bumps, are seen in Fabry's disease, which is a lysosomal disorder due to absence of alpha galactosidase A. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40137?source=see_link\">",
"       \"Clinical features and diagnosis of Fabry disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929229\">",
"    <span class=\"h2\">",
"     External genitalia",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypogonadism with small testicles or undescended testicles, and small penile size is common in Prader Willi syndrome (obesity, hypogonadism, hyperphagia, and mental retardation). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=see_link\">",
"       \"Clinical features, diagnosis, and treatment of Prader-Willi syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ambiguous genitalia may accompany x-linked lissencephaly and the syndrome of infantile spasms in association with",
"      <span class=\"nowrap\">",
"       hydranencephaly/lissencephaly",
"      </span>",
"      and agenesis of the corpus callosum due to mutations in the aristaless related homeobox (ARX) gene. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/15/1273?source=see_link\">",
"       \"Etiology and pathogenesis of infantile spasms\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Macro-orchidism is common in Fragile X syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34889?source=see_link\">",
"       \"Clinical features and diagnosis of fragile X syndrome in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with x-linked adrenoleukodystrophy may manifest hyperpigmentation initially over the external genitalia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/56/33673?source=see_link\">",
"       \"Adrenoleukodystrophy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929237\">",
"    <span class=\"h2\">",
"     Lymphadenopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subacute and chronic inflammatory or neoplastic disorders (eg, toxoplasmosis, tuberculosis, infectious mononucleosis, and lymphoma) may be associated with enlargement of lymph nodes over multiple regions of the body. In some of these disorders there may be nonspecific neurologic symptoms such as lethargy or confusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929245\">",
"    <span class=\"h2\">",
"     Hepatosplenomegaly",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enlargement of the spleen and liver may be seen with the aforementioned infectious disorders. Lysosomal storage disorders, such as mucopolysaccharidoses and generalized GM1 gangliosidosis, and Niemann Pick disease can also lead to hepatosplenomegaly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7274?source=see_link\">",
"     \"Clinical features and diagnosis of the mucopolysaccharidoses\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/26/27047?source=see_link&amp;anchor=H11#H11\">",
"     \"Inborn errors of metabolism: Classification\", section on 'Lysosomal storage disorders'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20489?source=see_link\">",
"     \"Overview of Niemann-Pick disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929253\">",
"    <span class=\"h2\">",
"     Abnormal hair",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following disorders have both neurologic manifestations and abnormalities of hair. Such associations are reviewed elsewhere in more detail [",
"    <a class=\"abstract\" href=\"UTD.htm?14/17/14618/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Brittle hair is common in argininosuccinic aciduria. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20248?source=see_link\">",
"       \"Urea cycle disorders: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The hair in Menkes disease is brittle, sparse, and tortuous. A simple clue to the diagnosis is examining hair under low power of a light microscope. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39226?source=see_link&amp;anchor=H16#H16\">",
"       \"Overview of dietary trace minerals\", section on 'Menkes disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Alopecia is common in rhizomelic chondrodysplasia punctata and in Rubinstein Taybi syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8570?source=see_link&amp;anchor=H34#H34\">",
"       \"Peroxisomal disorders\", section on 'Rhizomelic chondrodysplasia punctata type 1'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/44/11978?source=see_link&amp;anchor=H2157284#H2157284\">",
"       \"Microdeletion syndromes (chromosomes 12 to 22)\", section on '16p13.3 deletion syndrome (Rubinstein-Taybi syndrome)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hirsutism and synophrys (joined eyebrows) are common in Cornelia de Lange syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19161?source=see_link&amp;anchor=H12#H12\">",
"       \"Approach to congenital malformations\", section on 'Syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A white forelock of hair may accompany the Waardenburg syndrome (heterochromia of the iris, bright blue eyes, broad and prominent nasal root, midface hypoplasia, and congenital sensorineural deafness). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24586?source=see_link&amp;anchor=H24#H24\">",
"       \"The genodermatoses\", section on 'Waardenburg syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929261\">",
"    <span class=\"h2\">",
"     Abnormal breath",
"    </span>",
"    &nbsp;&mdash;&nbsp;The area from which abnormal smells are most easily detected is the nape of the neck or the scalp. Infants with phenylketonuria may manifest a mousy odor. Those with isovaleric aciduria may have an odor of sweaty feet. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24489?source=see_link&amp;anchor=H2366118#H2366118\">",
"     \"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features\", section on 'Abnormal odors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929269\">",
"    <span class=\"h2\">",
"     Cardiovascular",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      High output cardiac failure is common in newborns and infants having vein of Galen malformations. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/54/5994?source=see_link&amp;anchor=H18#H18\">",
"       \"Hydrocephalus\", section on 'CNS malformations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A floppy and weak infant with cardiomegaly and poor cardiac contractility may have Pompe's disease (acid maltase deficiency or type II glycogen storage disease). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/20/17736?source=see_link\">",
"       \"Lysosomal acid maltase deficiency (glycogen storage disease II, Pompe disease)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Duchenne and Becker muscular dystrophies are associated with cardiomyopathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/16/1290?source=see_link\">",
"       \"Clinical features and diagnosis of Duchenne and Becker muscular dystrophy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with Friedreich's ataxia frequently manifest hypertrophic subaortic cardiomyopathy, as well as progressive ataxia and diabetes mellitus. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/4/15432?source=see_link\">",
"       \"Friedreich ataxia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with Barth&rsquo;s syndrome have congenital dilated cardiomyopathy as well as skeletal myopathy and neutropenia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1351?source=see_link&amp;anchor=H10#H10\">",
"       \"Inherited syndromes associated with cardiac disease\", section on 'Barth's syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929277\">",
"    <span class=\"h2\">",
"     Otolaryngology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Macroglossia is often noted when the tongue protrudes from between the teeth. Macroglossia is a characteristic of Beckwith-Wiedemann syndrome and some forms of mucopolysaccharidosis (eg, Hurler syndrome), and can also be seen in some patients with untreated hypothyroidism. Patients with macroglossia often have obstructive sleep apnea. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24473?source=see_link\">",
"     \"Beckwith-Wiedemann syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7274?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical features and diagnosis of the mucopolysaccharidoses\", section on 'Hurler syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10929285\">",
"    <span class=\"h1\">",
"     DEVELOPMENTAL SCREENING TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Developmental screening tests complement the history and neurologic examination, can be conducted in the field by trained health professionals, and may facilitate early diagnosis of a childhood neurological disability and appropriate intervention. There are several brief and accurate developmental screening tests that make use of information provided by the parents or direct observation or elicitation of developmental skills. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=see_link&amp;anchor=H4#H4\">",
"     \"Developmental and behavioral screening tests in primary care\", section on 'Developmental screening tests'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11304781\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete neurological assessment consists of a focused clinical history, a detailed neurological examination, and a general physical examination that focuses on features that may be related to neurologic disease. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In infants and children, the history should include information about prenatal exposures and symptoms and assessment of developmental milestones (",
"      <a class=\"graphic graphic_table graphicRef70142 \" href=\"UTD.htm?18/62/19436\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10928968\">",
"       'Pregnancy, perinatal, and neonatal history'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10928976\">",
"       'Developmental history'",
"      </a>",
"      above.) &nbsp; &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      Observations of infants and toddlers during play (eg, while stacking blocks or playing with an age-appropriate toy) can provide valuable information about the patient's attention span, gross and fine motor coordination, and problem solving abilities. These higher cortical functions are also assessed with a series of questions appropriate to the child&rsquo;s age (",
"      <a class=\"graphic graphic_table graphicRef78835 \" href=\"UTD.htm?18/23/18812\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10929007\">",
"       'Higher cortical functions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Each cranial nerve is tested by performance of a specific motor or sensory test. Testing in infants is often by observation for specific movements and responses and is less reliable. (See",
"      <a class=\"local\" href=\"#H10929015\">",
"       'Cranial nerves'",
"      </a>",
"      above.) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      The patient should be observed for abnormalities of posture and movements, including asymmetry at rest, fisting of the hand, frog-legged position suggesting hypotonia, tremor, myoclonus, or tics. (See",
"      <a class=\"local\" href=\"#H10930508\">",
"       'Posture and movements'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Muscle tone is the resistance felt upon passive movement of a joint through its range of motion. Hypotonia is characterized by decreased resistance to passive movement and hyperextension at the joints. Hypertonia can be either spastic in nature or",
"      <strong>",
"      </strong>",
"      characterized by muscle rigidity. (See",
"      <a class=\"local\" href=\"#H10930515\">",
"       'Tone and strength'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A sensory examination in young children is often imprecise, and only gross deficits can be detected. In children older than five to six years, sensory function is evaluated in the same manner as in an adult. (See",
"      <a class=\"local\" href=\"#H10929133\">",
"       'Sensory system'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Developmental reflexes (also known as primitive reflexes) appear at a certain time during the course of brain development, and normally disappear with progressive maturation of cortical inhibitory functions (",
"      <a class=\"graphic graphic_table graphicRef58453 \" href=\"UTD.htm?26/3/26684\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10929149\">",
"       'Developmental reflexes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Certain elements of the general physical examination may provide clues to the diagnosis of childhood neurological disorders. Important features include facial dysmorphism, abnormalities of skin pigmentation, color and texture of hair, breath odor, hepatosplenomegaly, and evidence of cardiac disease. (See",
"      <a class=\"local\" href=\"#H10929205\">",
"       'Elements of the general physical examination relevant to child neurology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Swaiman KF. Neurologic examination of the older child. In: Neurology. Principles and Practice, 4th, Swaiman KF, Ashwal S, Ferriero DM (Eds), Mosby Elsevier, Philadelphia 2006. p.17.",
"    </li>",
"    <li>",
"     Caramant L, Diadori P. The neurologic examination. In: Current Management in Child Neurology, 2nd, Maria BL (Ed), BC Dekker, Inc, 2002. p.28.",
"    </li>",
"    <li>",
"     Glascoe FP, Marks KP. Screening for developmental and behavioral problems. In: Neurodevelopmental Disabilities: Clinical and Scientific Foundations, Shevell M (Ed), MacKeith Press for the International Child Neurology Association, London 2009. p.85.",
"    </li>",
"    <li>",
"     Larsen PD and Stensaas SS. Pediatric NeuroLogic Examination videos and descriptions, 2009. Available at: file://library.med.utah.edu/pedineurologicexam/html/home_exam.html (Accessed on March 22, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14618/abstract/5\">",
"      Kutscher ML. How to think like a neurologist -- Part 1: Pearls of the neurological examination. Emergency and Office Pediatrics 1998; 11:101.",
"     </a>",
"    </li>",
"    <li>",
"     Medical Research Council. Aids to the examination of the peripheral nervous system. Memorandum No. 45. Her Majesty's Stationery Office, London, 1976.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14618/abstract/7\">",
"      Zafeiriou DI. Primitive reflexes and postural reactions in the neurodevelopmental examination. Pediatr Neurol 2004; 31:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14618/abstract/8\">",
"      Schott JM, Rossor MN. The grasp and other primitive reflexes. J Neurol Neurosurg Psychiatry 2003; 74:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/17/14618/abstract/9\">",
"      MARDEN PM, SMITH DW, MCDONALD MJ. CONGENITAL ANOMALIES IN THE NEWBORN INFANT, INCLUDING MINOR VARIATIONS. A STUDY OF 4,412 BABIES BY SURFACE EXAMINATION FOR ANOMALIES AND BUCCAL SMEAR FOR SEX CHROMATIN. J Pediatr 1964; 64:357.",
"     </a>",
"    </li>",
"    <li>",
"     Jones KL. Smith's Recognizable Patterns of Human Malformations, Jones KL (Ed), WB Saunders, Philadelphia 1988. p.662.",
"    </li>",
"    <li>",
"     Michelson DJ, Shu SK. Cognitive and motor regression. In: Pediatric Neurology: Principles and Practice, 4th, Swaiman KF, Ashwal S, Ferriero DM (Eds), Mosby Elsevier, Philadelphia 2006. p.821.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15360 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-110.137.129.113-48EA216BE4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14618=[""].join("\n");
var outline_f14_17_14618=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11304781\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10929372\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10928921\">",
"      THE CASE HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10928936\">",
"      History of present illness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10928944\">",
"      Medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10928952\">",
"      Allergy history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10928960\">",
"      Family history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10928968\">",
"      Pregnancy, perinatal, and neonatal history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10928976\">",
"      Developmental history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10928984\">",
"      Review of other systems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10928992\">",
"      NEUROLOGIC EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10928999\">",
"      General concepts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929007\">",
"      Higher cortical functions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929015\">",
"      Cranial nerves",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10929022\">",
"      - I (olfactory)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10929029\">",
"      - II (optic)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10929043\">",
"      - III (oculomotor), IV (trochlear), and VI (abducens)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10929058\">",
"      - V (trigeminal)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10929065\">",
"      - VII (facial)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21350096\">",
"      - VIII (vestibulocochlear)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10929080\">",
"      - IX (glossopharyngeal) and X (vagus)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10929095\">",
"      - XI (spinal accessory)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10929110\">",
"      - XII (hypoglossal)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929125\">",
"      Motor system",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10930508\">",
"      - Posture and movements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10930515\">",
"      - Tone and strength",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10930531\">",
"      - Coordination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929133\">",
"      Sensory system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929141\">",
"      Tendon reflexes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929149\">",
"      Developmental reflexes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929173\">",
"      Superficial reflexes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929181\">",
"      Gait",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929189\">",
"      Spine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929197\">",
"      Head",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10929205\">",
"      ELEMENTS OF THE GENERAL PHYSICAL EXAMINATION RELEVANT TO CHILD NEUROLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929213\">",
"      Dysmorphic features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929221\">",
"      Skin examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929229\">",
"      External genitalia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929237\">",
"      Lymphadenopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929245\">",
"      Hepatosplenomegaly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929253\">",
"      Abnormal hair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929261\">",
"      Abnormal breath",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929269\">",
"      Cardiovascular",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10929277\">",
"      Otolaryngology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10929285\">",
"      DEVELOPMENTAL SCREENING TESTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11304781\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/15360\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/15360|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/23/29040\" title=\"figure 1\">",
"      Corneal light reflex",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/15360|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/1/4112\" title=\"picture 1\">",
"      Normal optic disc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/62/26592\" title=\"picture 2\">",
"      Diffuse optic atrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/30/31215\" title=\"picture 3\">",
"      Papilledema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/14/19680\" title=\"picture 4\">",
"      Cherry red spot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/62/39919\" title=\"picture 5\">",
"      Dome shaped hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/15360|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/62/19436\" title=\"table 1\">",
"      Common developmental milestones",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/23/18812\" title=\"table 2\">",
"      Higher cortical function in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/3/26684\" title=\"table 3\">",
"      Developmental reflexes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/56/33673?source=related_link\">",
"      Adrenoleukodystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19161?source=related_link\">",
"      Approach to congenital malformations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24473?source=related_link\">",
"      Beckwith-Wiedemann syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/52/23369?source=related_link\">",
"      Causes and clinical manifestations of primary adrenal insufficiency in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10537?source=related_link\">",
"      Causes of short stature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=related_link\">",
"      Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2682?source=related_link\">",
"      Clinical features and detection of congenital hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=related_link\">",
"      Clinical features and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/16/1290?source=related_link\">",
"      Clinical features and diagnosis of Duchenne and Becker muscular dystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40137?source=related_link\">",
"      Clinical features and diagnosis of Fabry disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/4/34889?source=related_link\">",
"      Clinical features and diagnosis of fragile X syndrome in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/6/7274?source=related_link\">",
"      Clinical features and diagnosis of the mucopolysaccharidoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/33/29209?source=related_link\">",
"      Clinical features of cerebral palsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=related_link\">",
"      Clinical features, diagnosis, and treatment of Prader-Willi syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/56/2953?source=related_link\">",
"      Clinical manifestations and treatment of the hypermobility syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/47/6906?source=related_link\">",
"      Congenital anomalies and acquired abnormalities of the optic nerve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/0/23562?source=related_link\">",
"      Congenital cytogenetic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/18/8487?source=related_link\">",
"      Craniosynostosis syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=related_link\">",
"      Cytomegalovirus infection and disease in newborns, infants, children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=related_link\">",
"      Developmental and behavioral screening tests in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=related_link\">",
"      DiGeorge syndrome: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/54/3946?source=related_link\">",
"      Etiology and evaluation of macrocephaly in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36665?source=related_link\">",
"      Etiology and evaluation of microcephaly in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/54/24425?source=related_link\">",
"      Etiology and evaluation of the child with muscle weakness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/15/1273?source=related_link\">",
"      Etiology and pathogenesis of infantile spasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/19/44344?source=related_link\">",
"      Evaluation of hearing impairment in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/34/44581?source=related_link\">",
"      Facial clefts and holoprosencephaly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25257?source=related_link\">",
"      Facial nerve palsy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/44/12999?source=related_link\">",
"      Fourth cranial nerve (trochlear nerve) palsy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/4/15432?source=related_link\">",
"      Friedreich ataxia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32262?source=related_link\">",
"      Horner's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/54/5994?source=related_link\">",
"      Hydrocephalus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18058?source=related_link\">",
"      Hyperkinetic movement disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/26/27047?source=related_link\">",
"      Inborn errors of metabolism: Classification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/58/24489?source=related_link\">",
"      Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1351?source=related_link\">",
"      Inherited syndromes associated with cardiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/3/7225?source=related_link\">",
"      Lyme disease: Clinical manifestations in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/20/17736?source=related_link\">",
"      Lysosomal acid maltase deficiency (glycogen storage disease II, Pompe disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/14/34025?source=related_link\">",
"      Microdeletion syndromes (chromosomes 1 to 11)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/44/11978?source=related_link\">",
"      Microdeletion syndromes (chromosomes 12 to 22)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=related_link\">",
"      Neurofibromatosis type 1 (von Recklinghausen's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14505?source=related_link\">",
"      Neurological examination of the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/2/2088?source=related_link\">",
"      Newborn screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29175?source=related_link\">",
"      Nonepileptic paroxysmal disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20489?source=related_link\">",
"      Overview of Niemann-Pick disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/37/10841?source=related_link\">",
"      Overview of craniosynostosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39226?source=related_link\">",
"      Overview of dietary trace minerals",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/33/31255?source=related_link\">",
"      Overview of ptosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36105?source=related_link\">",
"      Overview of the routine management of the healthy newborn infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=related_link\">",
"      Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8570?source=related_link\">",
"      Peroxisomal disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/24/12681?source=related_link\">",
"      Prenatal screening for genetic disease in the Ashkenazi Jewish population",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16377?source=related_link\">",
"      Rhabdomyosarcoma and undifferentiated sarcoma in childhood and adolescence: Epidemiology, pathology, and molecular pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43046?source=related_link\">",
"      Sixth cranial nerve (abducens nerve) palsy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4727?source=related_link\">",
"      Sturge-Weber syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/15/250?source=related_link\">",
"      Syndromes with craniofacial abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10810?source=related_link\">",
"      Systemic lupus erythematosus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10073?source=related_link\">",
"      The child with tall stature or abnormally rapid growth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38377?source=related_link\">",
"      The detailed neurologic examination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24586?source=related_link\">",
"      The genodermatoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11194?source=related_link\">",
"      The pediatric physical examination: HEENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/34/40487?source=related_link\">",
"      Third cranial nerve (oculomotor nerve) palsy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/38/34410?source=related_link\">",
"      Tuberous sclerosis complex: Genetics, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/49/20248?source=related_link\">",
"      Urea cycle disorders: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24505?source=related_link\">",
"      Visual development and vision assessment in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21193?source=related_link\">",
"      Vitiligo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19304?source=related_link\">",
"      Weight gain and loss in pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_17_14619="Grading BM dysfunction Fanconi";
var content_f14_17_14619=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F57755&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F57755&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Grading of bone marrow dysfunction in patients with Fanconi anemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Absolute neutrophil count (per microL)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Platelet count (per microL)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Hemoglobin concentration, (g/dL)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mild",
"       </td>",
"       <td>",
"        &ge;1000",
"       </td>",
"       <td>",
"        &gt;50,000",
"       </td>",
"       <td>",
"        &ge;8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Moderate",
"       </td>",
"       <td>",
"        500 to &lt;1000",
"       </td>",
"       <td>",
"        30,000 to &lt;50,000",
"       </td>",
"       <td>",
"        &lt;8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe",
"       </td>",
"       <td>",
"        &lt;500",
"       </td>",
"       <td>",
"        &lt;30,000",
"       </td>",
"       <td>",
"        &lt;8",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Fanconi anemia: Guidelines for diagnosis and management, 3rd&nbsp;edition. Eiler ME, Frohnmayer D, Frohnmayer L et al, Eds, Eugene OR, 2008. Available at: file://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14619=[""].join("\n");
var outline_f14_17_14619=null;
var title_f14_17_14620="MGUS characteristics";
var content_f14_17_14620=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F73099&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F73099&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Characteristics of patients with monoclonal gammopathy of undetermined significance (MGUS)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Characteristic",
"       </td>",
"       <td class=\"subtitle1\">",
"        Screening study*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinically diagnosed MGUS&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\" rowspan=\"1\">",
"        Heavy",
"chain type (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        IgG",
"       </td>",
"       <td class=\"sublist_other\">",
"        69",
"       </td>",
"       <td class=\"sublist_other\">",
"        70",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        IgM",
"       </td>",
"       <td class=\"sublist_other\">",
"        17",
"       </td>",
"       <td class=\"sublist_other\">",
"        15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        IgA",
"       </td>",
"       <td class=\"sublist_other\">",
"        11",
"       </td>",
"       <td class=\"sublist_other\">",
"        12",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Biclonal",
"       </td>",
"       <td class=\"sublist_other\">",
"        3",
"       </td>",
"       <td class=\"sublist_other\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\" rowspan=\"1\">",
"        Light",
"chain type (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Kappa",
"       </td>",
"       <td class=\"sublist_other\">",
"        62",
"       </td>",
"       <td class=\"sublist_other\">",
"        61",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lambda",
"       </td>",
"       <td class=\"sublist_other\">",
"        38",
"       </td>",
"       <td class=\"sublist_other\">",
"        39",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduction in uninvolved immunoglobulins (percent)",
"       </td>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        38",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monoclonal urinary light chain detected (percent)",
"       </td>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        31",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Olmsted County prevalence study of 694 patients with MGUS diagnosed in a population- based screening study. Kyle, RA, Therneau, TM, Rajkumar, SV, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006; 354:1362.",
"     <br>",
"      &bull; Southeastern Minnesota study of 1384 patients with clinically diagnosed MGUS. Kyle, RA, Therneau, TM, Rajkumar, SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346:564.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14620=[""].join("\n");
var outline_f14_17_14620=null;
var title_f14_17_14621="Differential diagnosis of ALS";
var content_f14_17_14621=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F64932&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F64932&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of amyotrophic lateral sclerosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Disease",
"       </td>",
"       <td class=\"subtitle1\">",
"        Distinguishing features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multifocal motor neuropathy",
"       </td>",
"       <td>",
"        Multifocal nerve conduction block, very high GM1 ganglioside antibody titers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cervical spondylosis or extramedullary tumor with compressive radiculopathy and myelopathy",
"       </td>",
"       <td>",
"        Sensory symptoms and signs, Lhermitte's symptom, LMN signs at level(s) of compression and UMN signs in legs, sphincter dysfunction, MRI of spine shows significant cord compression with intrinsic spinal cord signal abnormality",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Benign fasciculations",
"       </td>",
"       <td>",
"        No weakness or atrophy, no electromyographic abnormality of motor unit morphology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inclusion body myositis",
"       </td>",
"       <td>",
"        Disproportionate finger flexor weakness, no UMN signs, slow progression, diagnosis requires muscle biopsy, electromyography usually with myopathic features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Primary lateral sclerosis",
"       </td>",
"       <td>",
"        A clinical variant of ALS: Spastic paraparesis, often with pseudobulbar palsy, prominent spasticity and hyperreflexia, no LMN signs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Progressive bulbar palsy",
"       </td>",
"       <td>",
"        A clinical variant of ALS: Bulbar involvement predominates, pronounced dysarthria and dysphagia, limb musculature mostly spared",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Progressive muscular atrophy",
"       </td>",
"       <td>",
"        A clinical variant of ALS: Muscle weakness and atrophy with no UMN signs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myasthenia gravis",
"       </td>",
"       <td>",
"        Diplopia, ptosis, ocular dysmotility, weakness improved by acetylcholinesterase inhibitors, no UMN or LMN features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monomelic (benign focal) amyotrophy",
"       </td>",
"       <td>",
"        Onset usually in youth, slow and self limited course, no UMN features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hereditary spinal muscular atrophy",
"       </td>",
"       <td>",
"        Symmetric, slow course, no UMN signs, usually diagnostic changes detected in the survival motor neuron 1 gene (SMN1)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hereditary spastic paraplegia",
"       </td>",
"       <td>",
"        Slowly progressive lower extremity spastic UMN weakness, minimal or no LMN symptoms and/or signs, sphincter dysfunction, sensory symptoms and signs, HSP gene positive if available",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Post-polio progressive muscular atrophy",
"       </td>",
"       <td>",
"        Slow course, no UMN signs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kennedy syndrome (bulbospinal muscular atrophy)",
"       </td>",
"       <td>",
"        X-linked recessive disorder, slow progression, expansion of a CAG trinucleotide repeat (&gt;35 CAGs) in the androgen receptor gene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Late-onset Tay-Sachs disease (GM2 gangliosidosis)",
"       </td>",
"       <td>",
"        Late adolescent and early adult onset, progressive atrophic paralysis, hexosaminidase A deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Motor neuron syndromes with lymphoproliferative disorders",
"       </td>",
"       <td>",
"        Lymphoma (Hodgkin or non-Hodgkin), multiple myeloma, chronic lymphocytic leukemia, Waldenstrom's macroglobulinemia; some have paraproteinemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Motor neuron syndromes in lung, breast, and other cancers",
"       </td>",
"       <td>",
"        May improve on treatment of the tumor, may be paraneoplastic or coincidental",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Radiation brainstem injury/radiation myelopathy",
"       </td>",
"       <td>",
"        History of radiation therapy for cancer, location of injury within the radiation ports, delay of months to a few years from treatment, LMN symptoms and signs at the level of the injury, possible UMN symptoms and signs below the injury, possible sensory symptoms and signs below the level of the injury (eg, Lhermitte's symptom), self limited: does not progress to a diffuse LMN/UMN disorder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thyrotoxic myopathy with fasciculations",
"       </td>",
"       <td>",
"        Overt or covert hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intraspinal tumors and other lesions",
"       </td>",
"       <td>",
"        Imaging studies show syringomyelia, syringobulbia, or intraspinal tumors",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LMN: lower motor neuron; UMN: upper motor neuron.",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Layzer RB. Chapter 415. Hereditary and acquired intrinsic motor neuron diseases. In: Bennett and Plum (Eds), Cecil Textbook of Medicine, W.B. Saunders, Philadelphia 1999.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14621=[""].join("\n");
var outline_f14_17_14621=null;
var title_f14_17_14622="Contents: Pediatric gynecology";
var content_f14_17_14622=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?17/55/18302\">",
"       Pediatrics",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric gynecology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric gynecology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Evaluation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/19/43316\">",
"           Gynecologic examination of the newborn and child",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Inflammation and infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/0/1032\">",
"           Clinical features and diagnosis of pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/45/11992\">",
"           Pathogenesis of and risk factors for pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/51/37689\">",
"           Sexually transmitted diseases: Overview of issues specific to adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/63/35832\">",
"           Treatment of pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/29/26072\">",
"           Vulvovaginal complaints in the prepubertal child",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Menstrual issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/23/25975\">",
"           Definition and evaluation of abnormal uterine bleeding in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/8/11402\">",
"           Diagnosis and treatment of endometriosis in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/57/11160\">",
"           Differential diagnosis and approach to the adolescent with abnormal uterine bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/37/14937\">",
"           Evaluation of oligomenorrhea in adolescence",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/7/17529\">",
"           Management of abnormal uterine bleeding in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/2/27685\">",
"           Physiology of the normal menstrual cycle",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/25/31125\">",
"           Primary dysmenorrhea in adolescents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/40/9866\">",
"           Adolescent sexuality",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/13/42201\">",
"           Contraception: Overview of issues specific to adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/11/12473\">",
"           Diagnosis and management of congenital anomalies of the vagina",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Polycystic ovary syndrome",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/13/39130\">",
"           Clinical features and diagnosis of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/9/34970\">",
"           Definition, pathogenesis, and etiology of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/46/24297\">",
"           Treatment of polycystic ovary syndrome in adolescents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Puberty and adrenarche",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/5/19546\">",
"           Definition, etiology, and evaluation of precocious puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/57/22424\">",
"           Diagnosis and treatment of delayed puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/48/23302\">",
"           Normal adrenarche",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/25/1434\">",
"           Normal puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/62/21481\">",
"           Premature adrenarche",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/49/4889\">",
"           Treatment of precocious puberty",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tuboovarian disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/8/23690\">",
"           Ovarian and fallopian tube torsion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/34/21033\">",
"           Ovarian cysts and neoplasms in infants, children, and adolescents",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-6E322142EF-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f14_17_14622=[""].join("\n");
var outline_f14_17_14622=null;
var title_f14_17_14623="Planar xanthomas in PBC";
var content_f14_17_14623=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F57793&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F57793&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Planar xanthomas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 361px; height: 241px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bilateral planar xanthomas in the palms of a 35-year-old woman with primary biliary cirrhosis. Xanthomas started in the creases and expanded. At the time that the xanthomas began to form, the serum bilriubin level was 18.6 mg/dL and serum cholesterol concentration was 970 mg/dL (25.2 mmol/l).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_17_14623=[""].join("\n");
var outline_f14_17_14623=null;
      